Synchrony Financial (SYF) 10-Q 25 Apr 24 2024 Q1 Quarterly report Financial data

Cover Document

Cover Document - shares	3 Months Ended
	Mar. 31, 2024	Apr. 19, 2024
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	001-36560
Entity Registrant Name	SYNCHRONY FINANCIAL
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	51-0483352
Entity Address, Address Line One	777 Long Ridge Road
Entity Address, City or Town	Stamford,
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06902
City Area Code	203
Local Phone Number	585-2400
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Smaller Reporting Company	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		401,543,685
Entity Central Index Key	0001601712
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Common stock, par value $0.001 per share
Trading Symbol	SYF
Security Exchange Name	NYSE
Series A Preferred Stock
Entity Information [Line Items]
Title of 12(b) Security	Depositary Shares Each Representing a 1/40th Interest in a Share of 5.625% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A
Trading Symbol	SYFPrA
Security Exchange Name	NYSE
Series B Preferred Stock
Entity Information [Line Items]
Title of 12(b) Security	Depositary Shares Each Representing a 1/40th Interest in a Share of 8.250% Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B
Trading Symbol	SYFPrB
Security Exchange Name	NYSE

Condensed Consolidated Statemen

Condensed Consolidated Statements of Earnings (Unaudited) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Interest income:
Interest and fees on loans (Note 5)	[1]	$ 5,293	$ 4,616
Interest on cash and debt securities		275	170
Total interest income		5,568	4,786
Interest expense:
Interest on deposits		954	557
Interest on senior and subordinated unsecured notes		104	101
Total interest expense		1,163	735
Net interest income		4,405	4,051
Retailer share arrangements		(764)	(917)
Provision for credit losses (Note 5)		1,884	1,290
Net interest income, after retailer share arrangements and provision for credit losses		1,757	1,844
Other income:
Interchange revenue		241	232
Protection product revenue		141	115
Loyalty programs		(319)	(298)
Other (Note 3)		1,094	16
Total other income		1,157	65
Other expense:
Employee costs		496	451
Professional fees		220	186
Marketing and business development		125	131
Information processing		186	166
Other		179	185
Total other expense		1,206	1,119
Earnings before provision for income taxes		1,708	790
Provision for income taxes (Note 14)		415	189
Net earnings		1,293	601
Net earnings available to common stockholders		$ 1,282	$ 590
Earnings per share (Note 12)
Basic (in usd per share)		$ 3.17	$ 1.36
Diluted (in usd per share)		$ 3.14	$ 1.35
Variable Interest Entity, Primary Beneficiary
Interest income:
Interest and fees on loans (Note 5)		$ 1,000	$ 948
Interest expense:
Interest on borrowings of consolidated securitization entities		105	77
Provision for credit losses (Note 5)		$ 165	$ 120
[1] Deferred merchant discounts to be recognized in interest income at March 31, 2024 and December 31, 2023, were $1.8 billion and $1.9 billion, respectively, which are included in Accrued expenses and other liabilities in our Condensed Consolidated Statement of Financial Position.

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net earnings	$ 1,293	$ 601
Other comprehensive income (loss)
Debt securities	(1)	24
Currency translation adjustments	0	(1)
Employee benefit plans	0	0
Other comprehensive income (loss)	(1)	23
Comprehensive income	$ 1,292	$ 624

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Financial Position - USD ($) $ in Millions		Mar. 31, 2024	Dec. 31, 2023
Assets
Cash and equivalents		$ 20,021	$ 14,259
Debt securities (Note 4)		3,005	3,799
Total loan receivables	[1],[2]	101,733	102,988
Less: Allowance for credit losses		(10,905)	(10,571)
Loan receivables, net		90,828	92,417
Goodwill (Note 7)		1,073	1,018
Intangible assets, net (Note 7)		800	815
Other assets		5,446	4,915
Assets held for sale (Note 3)		0	256
Total assets		121,173	117,479
Deposits: (Note 8)
Interest-bearing deposit accounts		83,160	80,789
Non-interest-bearing deposit accounts		394	364
Total deposits		83,554	81,153
Borrowings: (Notes 6 and 9)
Senior and subordinated unsecured notes		8,117	8,715
Total borrowings	[3]	16,133	15,982
Accrued expenses and other liabilities		6,204	6,334
Liabilities held for sale (Note 3)		0	107
Total liabilities		105,891	103,576
Equity:
Preferred stock, par share value $0.001 per share; 1,250,000 and $750,000 shares authorized at March 31, 2024 and December 31, 2023, respectively; 1,250,000 and $750,000 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively, and aggregate liquidation preference of $1,250 at March 31, 2024 and $750 at December 31, 2023		1,222	734
Common Stock, par share value $0.001 per share; 4,000,000,000 shares authorized; 833,984,684 shares issued at both March 31, 2024 and December 31, 2023; 401,410,596 and 406,875,775 shares outstanding at March 31, 2024 and December 31, 2023, respectively		1	1
Additional paid-in capital		9,768	9,775
Retained earnings		19,790	18,662
Accumulated other comprehensive income (loss):
Debt securities		(34)	(33)
Currency translation adjustments		(38)	(38)
Employee benefit plans		3	3
Treasury stock, at cost; 432,574,088 and 427,108,909 shares at March 31, 2024 and December 31, 2023, respectively		(15,430)	(15,201)
Total equity		15,282	13,903
Total liabilities and equity		121,173	117,479
Unsecuritized loans held for investment
Assets
Total loan receivables		81,642	81,554
Restricted loans of consolidated securitization entities
Assets
Total loan receivables		20,091	21,434
Less: Allowance for credit losses		(1,800)	(1,900)
Loan receivables, net	[4]	18,259	19,537
Other assets	[5]	49	47
Total assets		18,308	19,584
Borrowings: (Notes 6 and 9)
Borrowings of consolidated securitization entities	[3]	8,016	7,267
Total liabilities		$ 8,047	$ 7,298
[1] At March 31, 2024 and December 31, 2023, loan receivables included deferred costs and purchase discounts, net of deferred income, of $(120) million and $213 million, respectively. (c) At March 31, 2024 and December 31, 2023, $23.2 billion and $22.4 billion, respectively, of loan receivables were pledged by the Bank as collateral to the Federal Reserve to secure Federal Reserve discount window advances. Total loan receivables include $20.1 billion and $21.4 billion of restricted loans of consolidated securitization entities at March 31, 2024 and December 31, 2023, respectively. See Note 6. Variable Interest Entities for further information on these restricted loans. Includes unamortized debt premiums, discounts and issuance costs. (b) The Company may redeem certain borrowings prior to their original contractual maturity dates in accordance with the optional redemption provision specified in the respective instruments. Includes $1.8 billion and $1.9 billion of related allowance for credit losses resulting in gross restricted loans of $20.1 billion and $21.4 billion at March 31, 2024 and December 31, 2023, respectively. Other assets

Consolidated Statements of Fina

Consolidated Statements of Financial Position Statement (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	1,250,000	750,000
Preferred Stock, Shares Outstanding	1,250,000	750,000
Preferred Stock, Shares Issued	1,250,000	750,000
Preferred Stock, Liquidation Preference, Value	$ 1,250	$ 750
Common stock par value (in usd per share)	$ 0.001	$ 0.001
Common Stock, Shares Authorized	4,000,000,000	4,000,000,000
Common Stock, Shares, Issued	833,984,684	833,984,684
Common Stock, Shares, Outstanding	401,410,596	406,875,775
Treasury Stock, Common, Shares	432,574,088	427,108,909

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($) $ in Millions	Total	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjusted Balance	Preferred Stock	Common Stock	Additional Paid-in Capital	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Preferred stock, beginning balance (in shares) at Dec. 31, 2022				750,000
Beginning balance at Dec. 31, 2022	$ 12,873		$ 13,095	$ 734	$ 1	$ 9,718	$ 16,716		$ 16,938	$ (125)	$ (14,171)
Beginning balance (Accounting Standards Update 2016-13) at Dec. 31, 2022		$ 222						$ 222
Beginning balance (in shares) at Dec. 31, 2022					833,985,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	601						601
Other comprehensive income	23									23
Purchases of treasury stock											(404)
Treasury Stock Reissued at Lower than Repurchase Price							(59)
Stock-based compensation (in shares)					0
Stock-based compensation	$ (11)					(13)					61
Preferred Stock, Dividends Per Share, Declared	$ 14.06
Common Stock, Dividends, Per Share, Declared	$ 0.23
Dividends - preferred stock	$ (11)						(11)
Dividends - common stock	(100)						(100)
Preferred stock, ending balance (in shares) at Mar. 31, 2023				750,000
Ending balance at Mar. 31, 2023	$ 13,193			$ 734	$ 1	9,705	17,369			(102)	(14,514)
Ending balance (in shares) at Mar. 31, 2023					833,985,000
Preferred stock, beginning balance (in shares) at Dec. 31, 2023	750,000			750,000
Beginning balance at Dec. 31, 2023	$ 13,903			$ 734	$ 1	9,775	18,662			(68)	(15,201)
Beginning balance (in shares) at Dec. 31, 2023	833,984,684				833,985,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	$ 1,293						1,293
Other comprehensive income	(1)									(1)
Stock Issued During Period, Value, New Issues	488			$ 488
Stock Issued During Period, Shares, New Issues				500,000
Purchases of treasury stock	(300)										(300)
Treasury Stock Reissued at Lower than Repurchase Price							(52)
Stock-based compensation (in shares)					0
Stock-based compensation	$ 12					(7)					71
Preferred Stock, Dividends Per Share, Declared	$ 14.06
Common Stock, Dividends, Per Share, Declared	$ 0.25
Dividends - preferred stock	$ (11)						(11)
Dividends - common stock	$ (102)						(102)
Preferred stock, ending balance (in shares) at Mar. 31, 2024	1,250,000			1,250,000
Ending balance at Mar. 31, 2024	$ 15,282			$ 1,222	$ 1	$ 9,768	$ 19,790			$ (69)	$ (15,430)
Ending balance (in shares) at Mar. 31, 2024	833,984,684				833,985,000

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Unaudited) $ in Millions	3 Months Ended
	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)
Cash flows - operating activities
Net earnings	$ 1,293	$ 601
Adjustments to reconcile net earnings to cash provided from operating activities
Provision for credit losses	1,884	1,290
Deferred income taxes	27	(88)
Depreciation and amortization	119	111
(Increase) decrease in interest and fees receivable	(2)	(34)
(Increase) decrease in other assets	45	19
Increase (decrease) in accrued expenses and other liabilities	(204)	(177)
Gain on sale of business	(1,069)	0
All other operating activities	155	164
Cash provided from (used for) operating activities	2,248	1,886
Cash flows - investing activities
Maturity and sales of debt securities	982	1,458
Purchases of debt securities	(163)	(391)
Acquisitions, net of cash acquired	(1,935)	0
Proceeds from sale of business, net of cash and restricted cash sold	491	0
Net (increase) decrease in loan receivables, including held for sale	1,504	(234)
All other investing activities	(81)	(141)
Cash provided from (used for) investing activities	798	692
Borrowings of consolidated securitization entities
Proceeds from issuance of securitized debt	747	250
Maturities and repayment of securitized debt	0	(250)
Senior and subordinated unsecured notes
Proceeds from issuance of senior unsecured notes	0	740
Maturities and repayment of senior unsecured notes	(600)	0
Dividends paid on preferred stock	(11)	(11)
Proceeds from Issuance of Preferred Stock and Preference Stock	488	0
Net increase (decrease) in deposits	2,396	2,720
Purchases of treasury stock	(300)	(404)
Dividends paid on common stock	(102)	(100)
All other financing activities	(14)	(33)
Cash provided from (used for) financing activities	2,604	2,912
Increase (decrease) in cash and equivalents, including restricted amounts	5,650	5,490
Cash and equivalents, including restricted amounts, at beginning of period	14,421	10,430
Cash and equivalents	20,021	15,303
Restricted cash and equivalents included in other assets	50	617
Total cash and equivalents, including restricted amounts, at end of period	$ 20,071	$ 15,920

Business Description

Business Description	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business Description	BUSINESS DESCRIPTION Synchrony Financial (the “Company”) provides a range of credit products through financing programs it has established with a diverse group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations and healthcare service providers. We primarily offer private label, Dual Card, co-brand and general purpose credit cards, as well as short- and long-term installment loans, and savings products insured by the Federal Deposit Insurance Corporation (“FDIC”) through Synchrony Bank (the “Bank”). References to the “Company”, “we”, “us” and “our” are to Synchrony Financial and its consolidated subsidiaries unless the context otherwise requires.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying condensed consolidated financial statements were prepared in conformity with U.S. generally accepted accounting principles (“GAAP”). Preparing financial statements in conformity with U.S. GAAP requires us to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions (for example, unemployment, housing, interest rates and market liquidity) which affect reported amounts and related disclosures in our condensed consolidated financial statements. Although our current estimates contemplate current conditions and how we expect them to change in the future, as appropriate, it is reasonably possible that actual conditions could be different than anticipated in those estimates, which could materially affect our results of operations and financial position. Among other effects, such changes could result in incremental losses on loan receivables, future impairments of debt securities, goodwill and intangible assets, increases in reserves for contingencies, establishment of valuation allowances on deferred tax assets and increases in our tax liabilities. We primarily conduct our business within the United States and substantially all of our revenues are from U.S. customers. The operating activities conducted by our non-U.S. affiliates use the local currency as their functional currency. The effects of translating the financial statements of these non-U.S. affiliates to U.S. dollars are included in equity. Asset and liability accounts are translated at period-end exchange rates, while revenues and expenses are translated at average rates for the respective periods. Consolidated Basis of Presentation The Company’s financial statements have been prepared on a consolidated basis. Under this basis of presentation, our financial statements consolidate all of our subsidiaries – i.e., entities in which we have a controlling financial interest, most often because we hold a majority voting interest. To determine if we hold a controlling financial interest in an entity, we first evaluate if we are required to apply the variable interest entity (“VIE”) model to the entity, otherwise the entity is evaluated under the voting interest model. We consolidate certain securitization entities under the VIE model. See Note 6. Variable Interest Entities . Interim Period Presentation The condensed consolidated financial statements and notes thereto are unaudited. These statements include all adjustments (consisting of normal recurring accruals) that we considered necessary to present a fair statement of our results of operations, financial position and cash flows. The results reported in these condensed consolidated financial statements should not be considered as necessarily indicative of results that may be expected for the entire year. These condensed consolidated financial statements should be read in conjunction with our 2023 annual consolidated financial statements and the related notes in our Annual Report on Form 10-K for the year ended December 31, 2023 (our "2023 Form 10-K"). New Accounting Standards Recently Issued But Not Yet Adopted Accounting Standards In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This ASU improves reportable segment disclosure requirements and requires enhanced disclosures about significant segment expenses. The Company will adopt this guidance on a retrospective basis on its effective date, which for us is beginning within our December 31, 2024 Form 10-K. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU requires disclosure of specific categories in the rate reconciliation, as well as additional qualitative information about the reconciliation, and additional disaggregated information about income taxes paid. The Company will adopt this guidance on its effective date, which for us is beginning within our December 31, 2025 Form 10-K, and is currently determining the method of adoption. Equity Method Investments We use the equity method of accounting for investments where we have significant influence, but not control, over the operating and financial policies of the investee. Our assessment of significant influence includes factors such as our ownership interest, legal form, and representation on the board of directors. The Company generally records the initial investment at cost or fair value, as appropriate. Subsequently, we adjust each investment for our proportionate share of net income or loss in the investee. We amortize, where appropriate, differences between the Company’s cost basis and underlying equity in net assets, which are reported in Other Income. The Company evaluates equity method investments for other-than-temporary impairment when events or changes in circumstance indicate that the carrying amount of the investment might not be recoverable. See Note 2. Basis of Presentation and Summary of Significant Accounting Policies to our 2023 annual consolidated financial statements in our 2023 Form 10-K, for additional information on our other significant accounting policies.

Acquisitions and Dispositions

Acquisitions and Dispositions	3 Months Ended
	Mar. 31, 2024
Business Combination and Asset Acquisition [Abstract]
Acquisitions and Dispositions	ACQUISITIONS AND DISPOSITIONS Ally Lending On March 1, 2024, we acquired Ally Financial Inc.'s point of sale financing business, ("Ally Lending") for cash consideration of $2.0 billion. This acquisition deepens our presence and reach in the home improvement and health and wellness sectors, including high-growth specialty areas such as roofing, HVAC, and windows, as well as in cosmetic, audiology, and dentistry. The Ally Lending acquisition has been accounted for as a business combination using the acquisition method of accounting and, accordingly, assets acquired and liabilities assumed were recorded at their estimated fair value as of the acquisition date. ($ in millions) Fair Value Estimate Assets acquired Cash $ 34 Loan receivables 1,875 Intangible assets, net 23 Other assets 2 Total $ 1,934 Liabilities assumed Other liabilities (16) Total net identifiable assets acquired $ 1,918 Less: Total cash consideration paid $ 1,969 Goodwill $ 51 The above represents the provisional estimated fair values of the respective assets acquired and liabilities assumed as of the date of acquisition. We have not yet completed the valuation of the assets acquired and liabilities assumed. Any subsequent measurement period adjustments to our provisional estimate, including changes to the loan discount discussed below, may be recognized during the measurement period, which shall not exceed one year after the acquisition date. The acquisition primarily included loan receivables with an unpaid principal balance of $2.2 billion. These loan receivables are reported within Consumer installment loans in Note 5. Loan Receivables and Allowance for Credit Losse . To determine the provisional fair value of loans at acquisition, we estimate expected cash flows and discount those cash flows using an observable market rate of interest, when available, adjusted for factors that a market participant would consider in determining fair value. In determining fair value, expected cash flows are adjusted to include prepayment, default rate, and loss severity estimates. The difference between the fair value and the amount contractually due is recorded as a loan discount or premium at acquisition. A provisional loan discount of $271 million was recorded at acquisition date, which is to be amortized into interest income over the estimated remaining life of the loans, as described within Note 2. Basis of Presentation and Summary of Significant Accounting Policies within our 2023 Form 10-K. Loans acquired without a more-than-insignificant credit deterioration since origination are measured under the Allowance for Credit Losses model, as described within Note 2. Basis of Presentation and Summary of Significant Accounting Policies within our 2023 Form 10-K. The Company’s best estimate at the date of acquisition of contractual cash flows not expected to be collected was $189 million, which is included within our allowance for credit losses and recognized through provision for credit losses in our Condensed Consolidated Statements of Earnings. Included in the acquisition was $64 million of loans that have experienced more-than-insignificant deterioration in credit quality since origination (referred to as “purchased credit deteriorated” or “PCD” assets) that were not immediately written off at the acquisition date and are subject to specific guidance upon acquisition. An allowance for PCD assets of $39 million was recorded at the date of acquisition. Subsequent to initial recognition, the accounting for the PCD assets will generally follow the Allowance for Credit Losses model described within Note 2. Basis of Presentation and Summary of Significant Accounting Policies of our 2023 Form 10-K. The results of operations related to the acquired business are included in our Condensed Consolidated Statements of Earnings subsequent to the acquisition date and were not material for the three months ended March 31, 2024. Pets Best In March 2024, we sold our wholly-owned subsidiary, Pets Best Insurance Services, LLC (“Pets Best”) to Poodle Holdings, Inc. (“Buyer”) for consideration comprising a combination of cash and an equity interest of less than 10% in Independence Pet Holdings, Inc., ("IPH") an affiliate of Buyer. In connection with the sale, IPH also appointed two Synchrony executives to its board of directors. The sale of Pets Best resulted in the recognition of a gain on sale of $1.1 billion or $802 million, net of tax. The pre-tax gain amount has been recognized within the Other component of Other Income in our Condensed Consolidated Statements of Earnings. The Company’s initial equity investment in IPH was recorded in Other Assets on our Condensed Consolidated Statements of Financial Position and is accounted for under the equity method of accounting. The investment was recorded at its estimated fair value at the date acquired of $605 million, which also represented the carrying value of the investment at March 31, 2024. The estimated fair value at acquisition date was determined using a weighted average methodology of three approaches: a market approach which includes using a multiple of projected revenues, precedent transactions and an intrinsic value analysis. The market-multiple approach was established based on a selected group of publicly traded companies. The use of selected precedent transaction multiples was calibrated to the valuation outcome using the market approach. Intrinsic value analysis determines implied multiples primarily based upon recent market studies and forecasted performance.

Debt Securities

Debt Securities	3 Months Ended
	Mar. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Investment Securities	DEBT SECURITIES All of our debt securities are classified as available-for-sale and are held to meet our liquidity objectives or to comply with the Community Reinvestment Act (“CRA”). Our debt securities consist of the following: March 31, 2024 December 31, 2023 Gross Gross Gross Gross Amortized unrealized unrealized Estimated Amortized unrealized unrealized Estimated ($ in millions) cost gains losses fair value cost gains losses fair value U.S. government and federal agency $ 1,463 $ — $ — $ 1,463 $ 2,264 $ 1 $ (1) $ 2,264 State and municipal 9 — — 9 10 — — 10 Residential mortgage-backed (a) 375 — (41) 334 392 — (38) 354 Asset-backed (b) 1,196 2 (7) 1,191 1,167 4 (8) 1,163 Other 8 — 8 8 — — 8 Total (c) $ 3,051 $ 2 $ (48) $ 3,005 $ 3,841 $ 5 $ (47) $ 3,799 _______________________ (a) All of our residential mortgage-backed securities have been issued by government-sponsored entities and are collateralized by U.S. mortgages. (b) Our asset-backed securities are collateralized by credit card and auto loans. (c) At March 31, 2024 and December 31, 2023, the estimated fair value of debt securities pledged by the Bank as collateral to the Federal Reserve to secure Federal Reserve discount window advances was $344 million and $360 million, respectively. The following table presents the estimated fair values and gross unrealized losses of our available-for-sale debt securities: In loss position for Less than 12 months 12 months or more Gross Gross Estimated unrealized Estimated unrealized ($ in millions) fair value losses fair value losses At March 31, 2024 U.S. government and federal agency $ 1,117 $ — $ — $ — State and municipal — — 6 — Residential mortgage-backed — — 328 (41) Asset-backed 304 (1) 277 (6) Other — — 8 — Total $ 1,421 $ (1) $ 619 $ (47) At December 31, 2023 U.S. government and federal agency $ 495 $ — $ 399 $ (1) State and municipal — — 9 — Residential mortgage-backed 1 — 346 (38) Asset-backed 171 — 244 (8) Other — — 8 — Total $ 667 $ — $ 1,006 $ (47) We regularly review debt securities for impairment resulting from credit loss using both qualitative and quantitative criteria, as necessary based on the composition of the portfolio at period end. Based on our assessment, no material impairments for credit losses were recognized during the period. We presently do not intend to sell our debt securities that are in an unrealized loss position and believe that it is not more likely than not that we will be required to sell these securities before recovery of our amortized cost. Contractual Maturities of Investments in Available-for-Sale Debt Securities Amortized Estimated Weighted At March 31, 2024 ($ in millions) cost fair value Average yield (a) Due Within one year $ 1,923 $ 1,918 4.9 % After one year through five years $ 766 $ 766 5.2 % After five years through ten years $ 169 $ 157 1.8 % After ten years $ 193 $ 164 2.0 % _____________________ (a) Weighted average yield is calculated based on the amortized cost of each security. In calculating yield, no adjustment has been made with respect to any tax-exempt obligations. All securities are presented above based upon contractual maturity date, except our asset-backed securities which are allocated based upon expected final payment date. We expect actual maturities to differ from contractual maturities because borrowers have the right to prepay certain obligations. There were no material realized gains or losses recognized for the three months ended March 31, 2024 and 2023.

Loan Receivables and Allowance

Loan Receivables and Allowance for Credit Losses	3 Months Ended
	Mar. 31, 2024
Receivables [Abstract]
Loan Receivables and Allowance for Credit Losses	LOAN RECEIVABLES AND ALLOWANCE FOR CREDIT LOSSES ($ in millions) March 31, 2024 December 31, 2023 Credit cards $ 93,736 $ 97,043 Consumer installment loans 5,957 3,977 Commercial credit products 1,912 1,839 Other 128 129 Total loan receivables, before allowance for credit losses (a)(b)(c) $ 101,733 $ 102,988 _______________________ (a) Total loan receivables include $20.1 billion and $21.4 billion of restricted loans of consolidated securitization entities at March 31, 2024 and December 31, 2023, respectively. See Note 6. Variable Interest Entities for further information on these restricted loans. (b) At March 31, 2024 and December 31, 2023, loan receivables included deferred costs and purchase discounts, net of deferred income, of $(120) million and $213 million, respectively. (c) At March 31, 2024 and December 31, 2023, $23.2 billion and $22.4 billion, respectively, of loan receivables were pledged by the Bank as collateral to the Federal Reserve to secure Federal Reserve discount window advances. Allowance for Credit Losses (a)(b) ($ in millions) Balance at Provision charged to operations (c) Gross charge-offs Recoveries Other (d) Balance at Credit cards $ 10,156 $ 1,508 $ (1,761) $ 291 $ — $ 10,194 Consumer installment loans 279 345 (90) 8 39 581 Commercial credit products 131 29 (35) 2 — 127 Other 5 (2) — — — 3 Total $ 10,571 $ 1,880 $ (1,886) $ 301 $ 39 $ 10,905 ($ in millions) Balance at Impact of ASU 2022-02 Adoption Post-Adoption Balance at January 1, 2023 Provision charged to operations Gross charge-offs Recoveries Balance at Credit cards $ 9,225 $ (294) $ 8,931 $ 1,159 $ (1,162) $ 224 $ 9,152 Consumer installment loans 208 1 209 85 (44) 5 255 Commercial credit products 87 (1) 85 48 (31) 2 104 Other 7 — 8 (2) — — 6 Total $ 9,527 $ (294) $ 9,233 $ 1,290 $ (1,237) $ 231 $ 9,517 _______________________ (a) The allowance for credit losses at March 31, 2024 and 2023 reflects our estimate of expected credit losses for the life of the loan receivables on our Condensed Consolidated Statements of Financial Position at March 31, 2024 and 2023 which include the consideration of current and expected macroeconomic conditions that existed at those dates. (b) Excluded from the table above are allowance for credit losses for loan receivables acquired and immediately written off within the period presented. (c) Provision for credit losses in the Condensed Consolidated Statements of Earnings for the three months ended March 31, 2024 includes $4 million associated with off-balance sheet credit exposures recorded in Accrued expenses and other liabilities in the Condensed Consolidated Statements of Financial Position. (d) Primarily represents allowance for credit losses for PCD assets. The reasonable and supportable forecast period used in our estimate of credit losses at March 31, 2024 was 12 months, consistent with the forecast period utilized since the adoption of CECL. Beyond the reasonable and supportable forecast period, we revert to historical loss information at the loan receivables segment level over a 6-month period, gradually increasing the weight of historical losses by an equal amount each month during the reversion period, and utilize historical loss information thereafter for the remaining life of the portfolio. The reversion period and methodology remain unchanged since the adoption of CECL. Losses on loan receivables, including those which are modified for borrowers experiencing financial difficulty, are estimated and recognized upon origination of the loan, based on expected credit losses for the life of the loan balance at March 31, 2024. Expected credit loss estimates are developed using both quantitative models and qualitative adjustments, and incorporates a macroeconomic forecast, as described within Note 2. Basis of Presentation and Summary of Significant Accounting Policies to our 2023 annual consolidated financial statements within our 2023 Form 10-K. The current and forecasted economic conditions at the balance sheet date influenced our current estimate of expected credit losses, which reflects our expectations of the macroeconomic environment. We continued to experience a decrease in payment rates and at March 31, 2024, total delinquent balances as a percentage of total loan receivables remained consistent with the prior quarter. We also experienced an increase in net charge-offs during the three months ended March 31, 2024 and expect net charge-offs to continue to increase in the first half of 2024. These conditions are reflected in our current estimate of expected credit losses, which remain generally consistent with the prior quarter. Our allowance for credit losses increased to $10.9 billion during the three months ended March 31, 2024, primarily reflecting the impact of the Ally Lending acquisition. See Note 2. Basis of Presentation and Summary of Significant Accounting Policies to our 2023 annual consolidated financial statements within our 2023 Form 10-K for additional information on our significant accounting policies related to our allowance for credit losses. Delinquent and Non-accrual Loans The following table provides information on our delinquent and non-accrual loans: At March 31, 2024 ($ in millions) 30-89 days delinquent 90 or more days delinquent Total past due 90 or more days delinquent and accruing Total non-accruing Credit cards $ 2,189 $ 2,377 $ 4,566 $ 2,377 $ — Consumer installment loans 121 33 154 — 33 Commercial credit products 51 49 100 49 — Total delinquent loans $ 2,361 $ 2,459 $ 4,820 $ 2,426 $ 33 Percentage of total loan receivables 2.3 % 2.4 % 4.7 % 2.4 % — % At December 31, 2023 ($ in millions) 30-89 days delinquent 90 or more days delinquent Total past due 90 or more days delinquent and accruing Total non-accruing Credit cards $ 2,375 $ 2,290 $ 4,665 $ 2,290 $ — Consumer installment loans 96 23 119 — 23 Commercial credit products 61 40 101 40 — Total delinquent loans $ 2,532 $ 2,353 $ 4,885 $ 2,330 $ 23 Percentage of total loan receivables 2.5 % 2.3 % 4.7 % 2.3 % — % Credit Quality Indicators Our loan receivables portfolio includes both secured and unsecured loans. Secured loan receivables are largely comprised of consumer installment loans secured by equipment. Unsecured loan receivables are largely comprised of our open-ended consumer and commercial revolving credit card loans. As part of our credit risk management activities, on an ongoing basis, we assess overall credit quality by reviewing information related to the performance of a customer’s account with us, including delinquency information, as well as information from credit bureaus relating to the customer’s broader credit performance. We utilize VantageScore credit scores to assist in our assessment of credit quality. VantageScore credit scores are obtained at origination of the account and are refreshed, at a minimum quarterly, but could be as often as weekly, to assist in predicting customer behavior. We categorize these credit scores into the following three credit score categories: (i) 651 or higher, which are considered the strongest credits; (ii) 591 to 650, considered moderate credit risk; and (iii) 590 or less, which are considered weaker credits. There are certain customer accounts, including for our commercial credit products, for which a VantageScore score is not available where we use alternative sources to assess their credit quality and predict behavior. The following table provides the most recent VantageScore scores, or equivalent, available for our revolving credit card and commercial credit product customers at March 31, 2024, December 31, 2023 and March 31, 2023, respectively, as a percentage of each class of loan receivable. The table below excludes 0.3%, 0.3% and 0.3% of our total loan receivables balance for our credit cards and commercial credit products at each of March 31, 2024, December 31, 2023 and March 31, 2023, respectively, which represents those customer accounts for which a VantageScore score, or equivalent, is not available. March 31, 2024 December 31, 2023 March 31, 2023 651 or 591 to 590 or 651 or 591 to 590 or 651 or 591 to 590 or higher 650 less higher 650 less higher 650 less Credit cards 71 % 20 % 9 % 72 % 19 % 9 % 73 % 19 % 8 % Commercial credit products 86 % 7 % 7 % 83 % 10 % 7 % 86 % 7 % 7 % Consumer Installment Loans Delinquency trends are the primary credit quality indicator for our consumer installment loans, which we use to monitor credit quality and risk within the portfolio. The tables below include information on our consumer installment loans by origination year. The amounts for the current year period include information related to the loans acquired through the Ally Lending acquisition. See Note 3. Acquisitions and Dispositions for additional information. Consumer Installment Loans by Origination Year By origination year At or for the three months ended 2024 2023 2022 2021 2020 Prior Total Amortized cost basis $ 809 $ 2,665 $ 1,470 $ 649 $ 287 $ 77 $ 5,957 30-89 days delinquent 4 53 38 16 7 3 121 90 or more days delinquent — 15 12 4 2 — 33 Current period gross charge-offs (a) — 47 25 12 5 1 90 By origination year At December 31, 2023 ($ in millions) 2023 2022 2021 2020 2019 Prior Total Amortized cost basis $ 2,097 $ 931 $ 541 $ 312 $ 69 $ 27 $ 3,977 30-89 days delinquent 44 25 15 9 2 1 96 90 or more days delinquent 11 6 4 2 — — 23 _______________________ (a) Gross charge-offs for the three months ended March 31, 2023 were not material. Loan Modifications to Borrowers Experiencing Financial Difficulty The Company adopted ASU 2022-02 at January 1, 2023 on a modified retrospective basis through a cumulative adjustment to retained earnings. The new guidance is applicable for all loans modified to borrowers experiencing financial difficulties since January 1, 2023. See Note 2. Basis of Presentation and Summary of Significant Accounting Policies - Allowance for Credit Losses -Loan Modifications to Borrowers Experiencing Financial Difficulty within our 2023 Form 10-K for additional information on our significant accounting policies related to loan modifications to borrowers experiencing financial difficulty. The following table provides information on our loan modifications made to borrowers experiencing financial difficulty during the periods presented, which do not include loans that are classified as loan receivables held for sale: Three months ended March 31 2024 2023 ($ in millions) Amount % of Loan Receivables Amount % of Loan Receivables Long-term modifications Credit cards $ 471 0.5 % $ 377 0.4 % Consumer installment loans — — — % Commercial credit products 2 0.1 % 1 0.1 % Short-term modifications Credit cards 247 0.3 % 139 0.2 % Consumer installment loans — — — % Commercial credit products — — — % Total $ 720 0.7 % $ 517 0.6 % Financial Effects of Loan Modifications to Borrowers Experiencing Financial Difficulty As part of our loan modifications to borrowers experiencing financial difficulty, we may provide multiple concessions to minimize our economic loss and improve long-term loan performance and collectability. For long-term modifications made in the three months ended March 31, 2024 and 2023, the financial effect of these modifications reduced the weighted-average interest rates by 97% for both periods, respectively. For short-term modifications made in the three months ended March 31, 2024 and 2023, unpaid balances of $15 million and $11 million, respectively, were forgiven. Performance of Loans Modified to Borrowers Experiencing Financial Difficulty The following tables provide information on the performance of loans modified to borrowers experiencing financial difficulty which have been modified within the previous 12 months and remain in a modification program at March 31, 2024. For the comparative period, amounts represent loans that were modified subsequent to January 1, 2023 and remained in a modification program at March 31, 2023: Amortized cost basis At March 31, 2024 ($ in millions) Current 30-89 days delinquent 90 or more days delinquent Total past due (a) Long-term modifications Credit cards $ 928 $ 175 $ 151 $ 326 Consumer installment loans — — — — Commercial credit products 2 1 1 2 Short-term modifications Credit cards 71 41 50 91 Consumer installment loans — — — — Commercial credit products — — — — Total delinquent modified loans $ 1,001 $ 217 $ 202 $ 419 Percentage of total loan receivables 1.0 % 0.2 % 0.2 % 0.4 % Amortized cost basis At March 31, 2023 ($ in millions) Current 30-89 days delinquent 90 or more days delinquent Total past due (a) Long-term modifications Credit cards $ 209 $ 89 $ 65 $ 154 Consumer installment loans — — — — Commercial credit products — — 1 1 Short-term modifications Credit cards 28 18 44 62 Consumer installment loans — — — — Commercial credit products — — — — Total delinquent modified loans $ 237 $ 107 $ 110 $ 217 Percentage of total loan receivables 0.3 % 0.1 % 0.1 % 0.2 % ___________________ (a) Once a loan has been modified, it only returns to current status (re-aged) after three consecutive monthly program payments are received post the modification date. Payment Defaults The following table presents the type, number and amount of loans to borrowers experiencing financial difficulty that enrolled in a long-term modification program within the previous 12 months from March 31, 2024, or between January 1, 2023 and March 31, 2023 for the comparative period, and experienced a payment default and charged-off during the period presented: Three months ended March 31 2024 2023 ($ in millions, accounts in thousands) Accounts defaulted Loans defaulted Accounts defaulted Loans defaulted Credit cards 47 $ 118 2 $ 7 Consumer installment loans — — — — Commercial credit products — 1 — — Total 47 $ 119 2 $ 7 Of the loans modified to borrowers experiencing financial difficulty that enrolled in a short-term modification program within the previous 12 months from March 31, 2024, or between January 1, 2023 and March 31, 2023 for the comparative period, 51% and 14% had fully completed all required payments and successfully exited the program during the three months ended March 31, 2024 and 2023, respectively. Unfunded Lending Commitments We manage the potential risk in credit commitments by limiting the total amount of credit, both by individual customer and in total, by monitoring the size and maturity of our portfolios and by applying the same credit standards for all of our credit products. Unused credit card lines available to our customers totaled approximately $428 billion and $427 billion at March 31, 2024 and December 31, 2023, respectively. While these amounts represented the total available unused credit card lines, we have not experienced and do not anticipate that all of our customers will access their entire available line at any given point in time. Interest Income by Product The following table provides additional information about our interest and fees on loans, including merchant discounts, from our loan receivables, including held for sale: Three months ended March 31, ($ in millions) 2024 2023 Credit cards (a) $ 5,096 $ 4,497 Consumer installment loans 149 83 Commercial credit products 45 34 Other 3 2 Total (b) $ 5,293 $ 4,616 _______________________ (a) Interest income on credit cards that was reversed related to accrued interest receivables written off was $592 million and $415 million for the three months ended March 31, 2024 and 2023, respectively. (b) Deferred merchant discounts to be recognized in interest income at March 31, 2024 and December 31, 2023, were $1.8 billion and $1.9 billion, respectively, which are included in Accrued expenses and other liabilities in our Condensed Consolidated Statement of Financial Position.

Variable Interest Entities

Variable Interest Entities	3 Months Ended
	Mar. 31, 2024
Variable Interest Entities [Abstract]
Variable Interest Entities	VARIABLE INTEREST ENTITIES We use VIEs to securitize loan receivables and arrange asset-backed financing in the ordinary course of business. Investors in these entities only have recourse to the assets owned by the entity and not to our general credit. We do not have implicit support arrangements with any VIE and we did not provide non-contractual support for previously transferred loan receivables to any of these VIEs in the three months ended March 31, 2024 and 2023. Our VIEs are able to accept new loan receivables and arrange new asset-backed financings, consistent with the requirements and limitations on such activities placed on the VIE by existing investors. Once an account has been designated to a VIE, the contractual arrangements we have require all existing and future loan receivables originated under such account to be transferred to the VIE. The amount of loan receivables held by our VIEs in excess of the minimum amount required under the asset-backed financing arrangements with investors may be removed by us under removal of accounts provisions. All loan receivables held by a VIE are subject to claims of third-party investors. In evaluating whether we have the power to direct the activities of a VIE that most significantly impact its economic performance, we consider the purpose for which the VIE was created, the importance of each of the activities in which it is engaged and our decision-making role, if any, in those activities that significantly determine the entity’s economic performance as compared to other economic interest holders. This evaluation requires consideration of all facts and circumstances relevant to decision-making that affects the entity’s future performance and the exercise of professional judgment in deciding which decision-making rights are most important. In determining whether we have the right to receive benefits or the obligation to absorb losses that could potentially be significant to a VIE, we evaluate all of our economic interests in the entity, regardless of form (debt, equity, management and servicing fees, and other contractual arrangements). This evaluation considers all relevant factors of the entity’s design, including: the entity’s capital structure, contractual rights to earnings or losses, subordination of our interests relative to those of other investors, as well as any other contractual arrangements that might exist that could have the potential to be economically significant. The evaluation of each of these factors in reaching a conclusion about the potential significance of our economic interests is a matter that requires the exercise of professional judgment. We consolidate VIEs where we have the power to direct the activities that significantly affect the VIEs' economic performance, typically because of our role as either servicer or administrator for the VIEs. The power to direct exists because of our role in the design and conduct of the servicing of the VIEs’ assets as well as directing certain affairs of the VIEs, including determining whether and on what terms debt of the VIEs will be issued. The loan receivables in these entities have risks and characteristics similar to our other financing receivables and were underwritten to the same standard. Accordingly, the performance of these assets has been similar to our other comparable loan receivables, and the blended performance of the pools of receivables in these entities reflects the eligibility criteria that we apply to determine which receivables are selected for transfer. Contractually, the cash flows from these financing receivables must first be used to pay third-party debt holders, as well as other expenses of the entity. Excess cash flows, if any, are available to us. The creditors of these entities have no claim on our other assets. The table below summarizes the assets and liabilities of our consolidated securitization VIEs described above: ($ in millions) March 31, 2024 December 31, 2023 Assets Loan receivables, net (a) $ 18,259 $ 19,537 Other assets (b) 49 47 Total $ 18,308 $ 19,584 Liabilities Borrowings $ 8,016 $ 7,267 Other liabilities 31 31 Total $ 8,047 $ 7,298 _______________________ (a) Includes $1.8 billion and $1.9 billion of related allowance for credit losses resulting in gross restricted loans of $20.1 billion and $21.4 billion at March 31, 2024 and December 31, 2023, respectively. (b) Includes $47 million and $45 million of segregated funds held by the VIEs at March 31, 2024 and December 31, 2023, respectively, which are classified as restricted cash and equivalents and included as a component of Other assets The balances presented above are net of intercompany balances and transactions that are eliminated in our condensed consolidated financial statements. We provide servicing for all of our consolidated VIEs. Collections are required to be placed into segregated accounts owned by each VIE in amounts that meet contractually specified minimum levels. These segregated funds are invested in cash and cash equivalents and are restricted as to their use, principally to pay maturing principal and interest on debt and the related servicing fees. Collections above these minimum levels are remitted to us on a daily basis. Income (principally, interest and fees on loans) earned by our consolidated VIEs was $1.0 billion and $948 million for the three months ended March 31, 2024 and 2023, respectively. Related expenses consisted primarily of provision for credit losses of $165 million and $120 million for the three months ended March 31, 2024 and 2023, respectively, and interest expense of $105 million and $77 million for the three months ended March 31, 2024 and 2023, respectively. These amounts do not include intercompany transactions, principally fees and interest, which are eliminated in our condensed consolidated financial statements. Non-consolidated VIEs As part of our community reinvestment initiatives, we invest in affordable housing properties and receive affordable housing tax credits for these investments. These investments included in our Condensed Consolidated Statement of Financial Position totaled $713 million and $736 million at March 31, 2024 and December 31, 2023, respectively, and represents our total exposure for these entities. For the three months ended March 31, 2024 and 2023, we recognized amortization expense of $23 million and $20 million, respectively, and tax credits and other tax benefits of $28 million and $24 million, respectively, associated with investments in affordable housing properties within income tax expense or benefit. Our other investments in non-consolidated VIEs, totaled $259 million and $252 million at March 31, 2024 and December 31, 2023, respectively. At March 31, 2024, the Company also had investment commitments of $192 million related to these investment s.

Intangible Assets

Intangible Assets	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill ($ in millions) 2024 Balance at January 1 $ 1,018 Change in amounts allocated to disposition of business (a) 4 Goodwill recognized upon acquisition 51 Balance at March 31 $ 1,073 _____________ (a) The change in the three months ended March 31, 2024 was based upon the carrying amount of net assets of Pets Best and the final valuation of consideration received at closing. Intangible Assets March 31, 2024 December 31, 2023 ($ in millions) Gross carrying amount Accumulated amortization Net Gross carrying amount Accumulated amortization Net Capitalized software $ 2,066 $ (1,331) $ 735 $ 2,065 $ (1,302) $ 763 Other 191 (126) 65 204 (152) 52 Total $ 2,257 $ (1,457) $ 800 $ 2,269 $ (1,454) $ 815 During the three months ended March 31, 2024, we recorded additions to intangible assets subject to amortization of $64 million, primarily related to capitalized software expenditures, as well as intangible assets of $23 million related to the Ally Lending acquisition. See Note 3. Acquisitions and Dispositions for additional information. Amortization expense was $80 million and $70 million for the three months ended March 31, 2024 and 2023, respectively, and is included as a component of Other expense in our Condensed Consolidated Statements of Earnings.

Deposits

Deposits	3 Months Ended
	Mar. 31, 2024
Deposits [Abstract]
Deposits	DEPOSITS March 31, 2024 December 31, 2023 ($ in millions) Amount Average rate (a) Amount Average rate (a) Interest-bearing deposits $ 83,160 4.6 % $ 80,789 3.9 % Non-interest-bearing deposits 394 — 364 — Total deposits $ 83,554 $ 81,153 ____________________ (a) Based on interest expense for the three months ended March 31, 2024 and the year ended December 31, 2023 and average deposits balances. At March 31, 2024 and December 31, 2023, interest-bearing deposits included $10.7 billion and $10.0 billion, respectively, of certificates of deposit that exceeded applicable FDIC insurance limits, which are generally $250,000 per depositor for each account ownership category. These amounts include partially insured certificates of deposit. At March 31, 2024, our interest-bearing time deposits maturing for the remainder of 2024 and over the next four years and thereafter were as follows: ($ in millions) 2024 2025 2026 2027 2028 Thereafter Deposits $ 25,691 $ 17,744 $ 1,719 $ 2,726 $ 1,455 $ 282 The above maturity table excludes $29.3 billion of demand deposits with no defined maturity, of which $27.3 billion are savings accounts. In addition, at March 31, 2024, we had $4.3 billion of broker network deposit sweeps procured through a program arranger who channels brokerage account deposits to us that are also excluded from the above maturity table. Unless extended, the contracts associated with these broker network deposit sweeps will terminate between 2025 and 2026.

Borrowings

Borrowings	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Borrowings	BORROWINGS March 31, 2024 December 31, 2023 ($ in millions) Maturity date Interest Rate Weighted average interest rate Outstanding Amount (a)(b) Outstanding Amount (a)(b) Borrowings of consolidated securitization entities: Fixed securitized borrowings 2025 - 2027 3.37% - 5.74% 4.69 % $ 4,166 $ 3,417 Floating securitized borrowings 2024 - 2026 6.07% - 6.28% 6.14 % 3,850 3,850 Total borrowings of consolidated securitization entities 5.39 % 8,016 7,267 Senior unsecured notes: Synchrony Financial senior unsecured notes: Fixed senior unsecured notes 2024 - 2031 2.87% - 5.15% 4.20 % 5,882 6,480 Synchrony Bank senior unsecured notes: Fixed senior unsecured notes 2025 - 2027 5.40% - 5.63% 5.49 % 1,494 1,494 Total senior unsecured notes 4.46 % 7,376 7,974 Subordinated unsecured notes: Synchrony Financial subordinated unsecured notes: Fixed subordinated unsecured notes 2033 7.25% 7.25 % 741 741 Total senior and subordinated unsecured notes 4.72 % 8,117 8,715 Total borrowings $ 16,133 $ 15,982 ___________________ (a) Includes unamortized debt premiums, discounts and issuance costs. (b) The Company may redeem certain borrowings prior to their original contractual maturity dates in accordance with the optional redemption provision specified in the respective instruments. Debt Maturities The following table summarizes the maturities of the principal amount of our borrowings of consolidated securitization entities and senior and subordinated unsecured notes for the remainder of 2024 and over the next four years and thereafter: ($ in millions) 2024 2025 2026 2027 2028 Thereafter Borrowings $ 2,875 $ 6,050 $ 2,750 $ 2,350 $ — $ 2,150 Additional Sources of Liquidity We have undrawn committed capacity under certain credit facilities, primarily related to our securitization programs and also have access to the Federal Reserve discount window. At March 31, 2024 and December 31, 2023, we had an aggregate of $2.5 billion of undrawn committed capacity under our securitization financings, subject to customary borrowing conditions, from private lenders under our securitization programs, and an aggregate of $0.5 billion of undrawn committed capacity under our unsecured revolving credit facility with private lenders.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	FAIR VALUE MEASUREMENTS For a description of how we estimate fair value, see Note 2. Basis of Presentation and Summary of Significant Accounting Policies in our 2023 annual consolidated financial statements within our 2023 Form 10-K. The following tables present our assets and liabilities measured at fair value on a recurring basis. Recurring Fair Value Measurements At March 31, 2024 ($ in millions) Level 1 Level 2 Level 3 Total (a) Assets Debt securities U.S. government and federal agency $ — $ 1,463 $ — $ 1,463 State and municipal — — 9 9 Residential mortgage-backed — 335 — 335 Asset-backed — 1,191 — 1,191 Other — — 8 8 Other (b) 14 — 9 23 Total $ 14 $ 2,989 $ 26 $ 3,029 Liabilities Other (c) — — 4 4 Total $ — $ — $ 4 $ 4 At December 31, 2023 ($ in millions) Assets Debt securities U.S. government and federal agency $ — $ 2,264 $ — $ 2,264 State and municipal — — 10 10 Residential mortgage-backed — 354 — 354 Asset-backed — 1,162 — 1,162 Other — — 8 8 Other (b) 14 — 10 24 Total $ 14 $ 3,780 $ 28 $ 3,822 Liabilities Other (c) — — $ 4 $ 4 Total $ — $ — $ 4 $ 4 _______________________ (a) For the three months ended March 31, 2024 and 2023, there were no fair value measurements transferred between levels. (b) Other is primarily comprised of equity investments measured at fair value, which are included in Other assets in our Condensed Consolidated Statement of Financial Position, as well as certain financial assets for which we have elected the fair value option which are included in Loan receivables in our Condensed Consolidated Statement of Financial Position. (c) Other is primarily comprised of certain financial liabilities for which we have elected the fair value option, which are included in Accrued expenses and other liabilities in our Condensed Consolidated Statement of Financial Position. Level 3 Fair Value Measurements Our Level 3 recurring fair value measurements primarily relate to state and municipal and corporate debt instruments, which are valued using non-binding broker quotes or other third-party sources, and financial assets and liabilities for which we have elected the fair value option. See Note 2. Basis of Presentation and Summary of Significant Accounting Policies and Note 10. Fair Value Measurements in our 2023 annual consolidated financial statements within our 2023 Form 10-K for a description of our process to evaluate third-party pricing servicers. Our state and municipal debt securities are classified as available-for-sale with changes in fair value included in Accumulated other comprehensive income. The changes in our Level 3 assets and liabilities that are measured on a recurring basis for the three months ended March 31, 2024 and 2023, respectively, were not material. Financial Assets and Financial Liabilities Carried at Other Than Fair Value Carrying Corresponding fair value amount At March 31, 2024 ($ in millions) value Total Level 1 Level 2 Level 3 Financial Assets Financial assets for which carrying values equal or approximate fair value: Cash and equivalents (a) $ 20,021 $ 20,021 $ 20,021 $ — $ — Other assets (a)(b) $ 50 $ 50 $ 50 $ — $ — Financial assets carried at other than fair value: Loan receivables, net (c) $ 90,819 $ 103,231 $ — $ — $ 103,231 Financial Liabilities Financial liabilities carried at other than fair value: Deposits $ 83,554 $ 83,516 $ — $ 83,516 $ — Borrowings of consolidated securitization entities $ 8,016 $ 8,001 $ — $ 4,150 $ 3,851 Senior and subordinated unsecured notes $ 8,117 $ 7,826 $ — $ 7,826 $ — Carrying Corresponding fair value amount At December 31, 2023 ($ in millions) value Total Level 1 Level 2 Level 3 Financial Assets Financial assets for which carrying values equal or approximate fair value: Cash and equivalents (a) $ 14,259 $ 14,259 $ 14,259 $ — $ — Other assets (a)(b) $ 50 $ 50 $ 50 $ — $ — Assets held for sale (d) $ 112 $ 112 $ 112 $ — $ — Financial assets carried at other than fair value: Loan receivables, net (c) $ 92,407 $ 104,761 $ — $ — $ 104,761 Financial Liabilities Financial liabilities carried at other than fair value: Deposits $ 81,153 $ 80,935 $ — $ 80,935 $ — Borrowings of consolidated securitization entities $ 7,267 $ 7,250 $ — $ 3,411 $ 3,839 Senior and subordinated unsecured notes $ 8,715 $ 8,423 $ — $ 8,423 $ — _______________________ (a) For cash and equivalents and restricted cash and equivalents, carrying value approximates fair value due to the liquid nature and short maturity of these instruments. (b) This balance relates to restricted cash and equivalents, which is included in Other assets. (c) Excludes financial assets for which we have elected the fair value option. Under certain retail partner program agreements, the expected sales proceeds in the event of a sale of their credit card portfolio may be limited to the amounts owed by our customers, which may be less than the fair value indicated above. (d) Includes $19 million of cash and equivalents and $93 million of restricted cash and equivalents.

Regulatory and Capital Adequacy

Regulatory and Capital Adequacy	3 Months Ended
	Mar. 31, 2024
Banking Regulation, Risk-Based Information [Abstract]
Regulatory and Capital Adequacy	REGULATORY AND CAPITAL ADEQUACY As a savings and loan holding company and a financial holding company, we are subject to regulation, supervision and examination by the Federal Reserve Board and subject to the capital requirements as prescribed by Basel III capital rules and the requirements of the Dodd-Frank Wall Street Reform and Consumer Protection Act. The Bank is a federally chartered savings association. As such, the Bank is subject to regulation, supervision and examination by the Office of the Comptroller of the Currency of the U.S. Treasury (the “OCC”), which is its primary regulator, and by the Consumer Financial Protection Bureau (“CFPB”). In addition, the Bank, as an insured depository institution, is supervised by the FDIC. Failure to meet minimum capital requirements can initiate certain mandatory and, possibly, additional discretionary actions by regulators that, if undertaken, could limit our business activities and have a material adverse effect on our consolidated financial statements. Under capital adequacy guidelines, we must meet specific capital guidelines that involve quantitative measures of our assets, liabilities and certain off-balance-sheet items as calculated under regulatory accounting practices. The capital amounts and classifications are also subject to qualitative judgments by the regulators about components, risk weightings and other factors. Quantitative measures established by regulation to ensure capital adequacy require us and the Bank to maintain minimum amounts and ratios (set forth in the tables below) of Total, Tier 1 and common equity Tier 1 capital (as defined in the regulations) to risk-weighted assets (as defined), and of Tier 1 capital to average assets (as defined). For Synchrony Financial to be a well-capitalized savings and loan holding company, the Bank must be well-capitalized and Synchrony Financial must not be subject to any written agreement, order, capital directive, or prompt corrective action directive issued by the Federal Reserve Board to meet and maintain a specific capital level for any capital measure. The Company elected to adopt the option provided by the interim final rule issued by joint federal bank regulatory agencies, which largely delayed the effects of CECL on its regulatory capital. Beginning in the first quarter of 2022, the effects are being phased-in over a three-year period through 2024 and will be fully phased-in beginning in the first quarter of 2025. Under the interim final rule, the amount of adjustments to regulatory capital deferred until the phase-in period included both the initial impact of our adoption of CECL at January 1, 2020 and 25% of subsequent changes in our allowance for credit losses during the two-year period ended December 31, 2021, collectively the “CECL regulatory capital transition adjustment”. Beginning in the first quarter of 2024 only 25% of the CECL regulatory capital transition adjustment is deferred in our regulatory capital amounts and ratios, as compared to 50% at December 31, 2023. At March 31, 2024 and December 31, 2023, Synchrony Financial met all applicable requirements to be deemed well-capitalized pursuant to Federal Reserve Board regulations. At March 31, 2024 and December 31, 2023, the Bank also met all applicable requirements to be deemed well-capitalized pursuant to OCC regulations and for purposes of the Federal Deposit Insurance Act. There are no conditions or events subsequent to March 31, 2024 that management believes have changed the Company's or the Bank’s capital category. The actual capital amounts, ratios and the applicable required minimums of the Company and the Bank are as follows: Synchrony Financial At March 31, 2024 ($ in millions) Actual Minimum for capital Amount Ratio (a) Amount Ratio (b) Total risk-based capital $ 16,347 15.8 % $ 8,259 8.0 % Tier 1 risk-based capital $ 14,207 13.8 % $ 6,195 6.0 % Tier 1 leverage $ 14,207 12.0 % $ 4,719 4.0 % Common equity Tier 1 Capital $ 12,985 12.6 % $ 4,646 4.5 % At December 31, 2023 ($ in millions) Actual Minimum for capital Amount Ratio (a) Amount Ratio (b) Total risk-based capital $ 15,464 14.9 % $ 8,277 8.0 % Tier 1 risk-based capital $ 13,334 12.9 % $ 6,208 6.0 % Tier 1 leverage $ 13,334 11.7 % $ 4,563 4.0 % Common equity Tier 1 Capital $ 12,600 12.2 % $ 4,656 4.5 % Synchrony Bank At March 31, 2024 ($ in millions) Actual Minimum for capital Minimum to be well-capitalized under prompt corrective action provisions Amount Ratio (a) Amount Ratio (b) Amount Ratio Total risk-based capital $ 14,769 15.1 % $ 7,840 8.0 % $ 9,800 10.0 % Tier 1 risk-based capital $ 12,690 12.9 % $ 5,880 6.0 % $ 7,840 8.0 % Tier 1 leverage $ 12,690 11.4 % $ 4,454 4.0 % $ 5,567 5.0 % Common equity Tier I capital $ 12,690 12.9 % $ 4,410 4.5 % $ 6,370 6.5 % At December 31, 2023 ($ in millions) Actual Minimum for capital Minimum to be well-capitalized under prompt corrective action provisions Amount Ratio (a) Amount Ratio (b) Amount Ratio Total risk-based capital $ 14,943 15.3 % $ 7,822 8.0 % $ 9,778 10.0 % Tier 1 risk-based capital $ 12,880 13.2 % $ 5,867 6.0 % $ 7,822 8.0 % Tier 1 leverage $ 12,880 12.0 % $ 4,302 4.0 % $ 5,377 5.0 % Common equity Tier I capital $ 12,880 13.2 % $ 4,400 4.5 % $ 6,356 6.5 % _______________________ (a) Capital ratios are calculated based on the Basel III Standardized Approach rules. Capital amounts and ratios at March 31, 2024 and at December 31, 2023 in the above tables reflect the applicable CECL regulatory capital transition adjustment. (b) At March 31, 2024 and at December 31, 2023, Synchrony Financial and the Bank also must maintain a capital conservation buffer of common equity Tier 1 capital in excess of minimum risk-based capital ratios by at least 2.5 percentage points to avoid limits on capital distributions and certain discretionary bonus payments to executive officers and similar employees.

Earnings Per Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Earnings Per Share	EARNINGS PER SHARE Basic earnings per share is computed by dividing earnings available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per common share reflects the assumed conversion of all dilutive securities, which are calculated using the treasury stock method. The following table presents the calculation of basic and diluted earnings per common share: Three months ended March 31, (in millions, except per share data) 2024 2023 Net earnings $ 1,293 $ 601 Preferred stock dividends (11) (11) Net earnings available to common stockholders $ 1,282 $ 590 Weighted average common shares outstanding, basic 404.7 434.4 Effect of dilutive securities 3.5 2.8 Weighted average common shares outstanding, dilutive 408.2 437.2 Earnings per basic common share $ 3.17 $ 1.36 Earnings per diluted common share $ 3.14 $ 1.35

EQUITY AND OTHER STOCK RELATED

EQUITY AND OTHER STOCK RELATED INFORMATION	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
Equity and Other Stock Related Information	EQUITY AND OTHER STOCK RELATED INFORMATION Preferred Stock The following table summarizes the Company's preferred stock issued and outstanding at March 31, 2024 and December 31, 2023. Series Issuance Date Redeemable by Issuer Beginning Per Annum Dividend Rate Liquidation Preference per Share Total Shares Outstanding March 31, 2024 December 31, 2023 ($ in millions, except per share data) Series A (a) November 14, 2019 November 15, 2024 5.625% $1,000 750,000 $ 734 $ 734 Series B (a) February 23, 2024 May 15, 2029 8.25% (b) $1,000 500,000 $ 488 $ — $ 1,222 $ 734 _______________________ (a) Issued as depositary shares, each representing a 1/40th interest in a share of the corresponding series of non-cumulative perpetual preferred stock. Dividends are payable quarterly on February 15, May 15, August 15 and November 15 of each calendar year at a fixed rate, in each case when, as and if declared by the Board of Directors. (b) Through May 14, 2029; resets May 15, 2029 and each date falling on the fifth anniversary at 5-Year Treasury Rate plus 4.044%.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES Unrecognized Tax Benefits ($ in millions) March 31, 2024 December 31, 2023 Unrecognized tax benefits, excluding related interest expense and penalties (a) $ 242 $ 230 Portion that, if recognized, would reduce tax expense and effective tax rate (b) $ 191 $ 182 ____________________ (a) Interest and penalties related to unrecognized tax benefits were not material for all periods presented. (b) Comprised of federal unrecognized tax benefits and state and local unrecognized tax benefits net of the effects of associated U.S. federal income taxes. Excludes amounts attributable to any related valuation allowances resulting from associated increases in deferred tax assets. We establish a liability that represents the difference between a tax position taken (or expected to be taken) on an income tax return and the amount of taxes recognized in our financial statements. The liability associated with the unrecognized tax benefits is adjusted periodically when new information becomes available. The amount of unrecognized tax benefits that is reasonably possible to be resolved in the next twelve months is expected to be $39 million, of which $31 million, if recognized, would reduce the Company's tax expense and effective tax rate. In the current year, the Company executed a Memorandum of Understanding with the IRS to participate voluntarily in the IRS Compliance Assurance Process (“CAP”) program for the 2024 tax year, and thus the tax year is under IRS review. The IRS is also examining our 2023 tax year, and we expect the review will be completed in the current year. Additionally, we are under examination in various states going back to 2014. We believe that there are no issues or claims that are likely to significantly impact our results of operations, financial position or cash flows. We further believe that we have made adequate provision for all income tax uncertainties that could result from such examinations.

Legal Proceedings and Regulator

Legal Proceedings and Regulatory Matters	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Legal Proceedings and Regulatory Matters	LEGAL PROCEEDINGS AND REGULATORY MATTERS In the normal course of business, from time to time, we have been named as a defendant in various legal proceedings, including arbitrations, class actions and other litigation, arising in connection with our business activities. Certain of the legal actions include claims for substantial compensatory and/or punitive damages, or claims for indeterminate amounts of damages. We are also involved, from time to time, in reviews, investigations and proceedings (both formal and informal) by governmental agencies regarding our business (collectively, “regulatory matters”), which could subject us to significant fines, penalties, obligations to change our business practices or other requirements resulting in increased expenses, diminished income and damage to our reputation. We contest liability and/or the amount of damages as appropriate in each pending matter. In accordance with applicable accounting guidance, we establish an accrued liability for legal and regulatory matters when those matters present loss contingencies which are both probable and reasonably estimable. Legal proceedings and regulatory matters are subject to many uncertain factors that generally cannot be predicted with assurance, and we may be exposed to losses in excess of any amounts accrued. For some matters, we are able to determine that an estimated loss, while not probable, is reasonably possible. For other matters, including those that have not yet progressed through discovery and/or where important factual information and legal issues are unresolved, we are unable to make such an estimate. We currently estimate that the reasonably possible losses for legal proceedings and regulatory matters, whether in excess of a related accrued liability or where there is no accrued liability, and for which we are able to estimate a possible loss, are immaterial. This represents management’s estimate of possible loss with respect to these matters and is based on currently available information. This estimate of possible loss does not represent our potential maximum loss exposure. The legal proceedings and regulatory matters underlying the estimate will change from time to time and actual results may vary significantly from current estimates. Our estimate of reasonably possible losses involves significant judgment, given the varying stages of the proceedings, the existence of numerous yet to be resolved issues, the breadth of the claims (often spanning multiple years), unspecified damages and/or the novelty of the legal issues presented. Based on our current knowledge, we do not believe that we are a party to any pending legal proceeding or regulatory matters that would have a material adverse effect on our condensed consolidated financial condition or liquidity. However, in light of the uncertainties involved in such matters, the ultimate outcome of a particular matter could be material to our operating results for a particular period depending on, among other factors, the size of the loss or liability imposed and the level of our earnings for that period, and could adversely affect our business and reputation. Below is a description of certain of our regulatory matters and legal proceedings. Other than as described below, during the quarter ended March 31, 2024, there were no material changes to the legal proceedings previously disclosed in our 2023 Form 10-K. On January 28, 2019, a purported shareholder derivative action, Gilbert v. Keane, et al. , was filed in the U.S. District Court for the District of Connecticut against the Company as a nominal defendant, and certain of the Company’s officers and directors. The lawsuit alleges breach of fiduciary duty claims based on the allegations raised by the plaintiff in the Stichting Depositary APG class action, unjust enrichment, waste of corporate assets, and that the defendants made materially misleading statements and/or omitted material information in violation of the Exchange Act. The complaint seeks a declaration that the defendants breached and/or aided and abetted the breach of their fiduciary duties to the Company, unspecified monetary damages with interest, restitution, a direction that the defendants take all necessary actions to reform and improve corporate governance and internal procedures, and attorneys’ and experts’ fees. On March 11, 2019, a second purported shareholder derivative action, Aldridge v. Keane, et al. , was filed in the U.S. District Court for the District of Connecticut. The allegations in the Aldridge complaint are substantially similar to those in the Gilbert complaint. On March 26, 2020, the District Court recaptioned the Gilbert and Aldridge cases as In re Synchrony Financial Derivative Litigation.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net earnings	$ 1,293	$ 601

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying condensed consolidated financial statements were prepared in conformity with U.S. generally accepted accounting principles (“GAAP”). Preparing financial statements in conformity with U.S. GAAP requires us to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions (for example, unemployment, housing, interest rates and market liquidity) which affect reported amounts and related disclosures in our condensed consolidated financial statements. Although our current estimates contemplate current conditions and how we expect them to change in the future, as appropriate, it is reasonably possible that actual conditions could be different than anticipated in those estimates, which could materially affect our results of operations and financial position. Among other effects, such changes could result in incremental losses on loan receivables, future impairments of debt securities, goodwill and intangible assets, increases in reserves for contingencies, establishment of valuation allowances on deferred tax assets and increases in our tax liabilities. We primarily conduct our business within the United States and substantially all of our revenues are from U.S. customers. The operating activities conducted by our non-U.S. affiliates use the local currency as their functional currency. The effects of translating the financial statements of these non-U.S. affiliates to U.S. dollars are included in equity. Asset and liability accounts are translated at period-end exchange rates, while revenues and expenses are translated at average rates for the respective periods. Consolidated Basis of Presentation The Company’s financial statements have been prepared on a consolidated basis. Under this basis of presentation, our financial statements consolidate all of our subsidiaries – i.e., entities in which we have a controlling financial interest, most often because we hold a majority voting interest. To determine if we hold a controlling financial interest in an entity, we first evaluate if we are required to apply the variable interest entity (“VIE”) model to the entity, otherwise the entity is evaluated under the voting interest model. We consolidate certain securitization entities under the VIE model. See Note 6. Variable Interest Entities .
Interim Period Presentation	Interim Period Presentation The condensed consolidated financial statements and notes thereto are unaudited. These statements include all adjustments (consisting of normal recurring accruals) that we considered necessary to present a fair statement of our results of operations, financial position and cash flows. The results reported in these condensed consolidated financial statements should not be considered as necessarily indicative of results that may be expected for the entire year. These condensed consolidated financial statements should be read in conjunction with our 2023 annual consolidated financial statements and the related notes in our Annual Report on Form 10-K for the year ended December 31, 2023 (our "2023 Form 10-K").
New Accounting Standards	New Accounting Standards Recently Issued But Not Yet Adopted Accounting Standards In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This ASU improves reportable segment disclosure requirements and requires enhanced disclosures about significant segment expenses. The Company will adopt this guidance on a retrospective basis on its effective date, which for us is beginning within our December 31, 2024 Form 10-K. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU requires disclosure of specific categories in the rate reconciliation, as well as additional qualitative information about the reconciliation, and additional disaggregated information about income taxes paid. The Company will adopt this guidance on its effective date, which for us is beginning within our December 31, 2025 Form 10-K, and is currently determining the method of adoption.
Equity Method Investments	Equity Method Investments We use the equity method of accounting for investments where we have significant influence, but not control, over the operating and financial policies of the investee. Our assessment of significant influence includes factors such as our ownership interest, legal form, and representation on the board of directors. The Company generally records the initial investment at cost or fair value, as appropriate. Subsequently, we adjust each investment for our proportionate share of net income or loss in the investee. We amortize, where appropriate, differences between the Company’s cost basis and underlying equity in net assets, which are reported in Other Income. The Company evaluates equity method investments for other-than-temporary impairment when events or changes in circumstance indicate that the carrying amount of the investment might not be recoverable.

Acquisitions and Dispositions (

Acquisitions and Dispositions (Tables)	3 Months Ended
	Mar. 31, 2024
Business Combination and Asset Acquisition [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	($ in millions) Fair Value Estimate Assets acquired Cash $ 34 Loan receivables 1,875 Intangible assets, net 23 Other assets 2 Total $ 1,934 Liabilities assumed Other liabilities (16) Total net identifiable assets acquired $ 1,918 Less: Total cash consideration paid $ 1,969 Goodwill $ 51

Debt Securities (Tables)

Debt Securities (Tables)	3 Months Ended
	Mar. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Schedule of Available-for-sale Securities Reconciliation	Our debt securities consist of the following: March 31, 2024 December 31, 2023 Gross Gross Gross Gross Amortized unrealized unrealized Estimated Amortized unrealized unrealized Estimated ($ in millions) cost gains losses fair value cost gains losses fair value U.S. government and federal agency $ 1,463 $ — $ — $ 1,463 $ 2,264 $ 1 $ (1) $ 2,264 State and municipal 9 — — 9 10 — — 10 Residential mortgage-backed (a) 375 — (41) 334 392 — (38) 354 Asset-backed (b) 1,196 2 (7) 1,191 1,167 4 (8) 1,163 Other 8 — 8 8 — — 8 Total (c) $ 3,051 $ 2 $ (48) $ 3,005 $ 3,841 $ 5 $ (47) $ 3,799 _______________________ (a) All of our residential mortgage-backed securities have been issued by government-sponsored entities and are collateralized by U.S. mortgages. (b) Our asset-backed securities are collateralized by credit card and auto loans. (c) At March 31, 2024 and December 31, 2023, the estimated fair value of debt securities pledged by the Bank as collateral to the Federal Reserve to secure Federal Reserve discount window advances was $344 million and $360 million, respectively.
Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value	The following table presents the estimated fair values and gross unrealized losses of our available-for-sale debt securities: In loss position for Less than 12 months 12 months or more Gross Gross Estimated unrealized Estimated unrealized ($ in millions) fair value losses fair value losses At March 31, 2024 U.S. government and federal agency $ 1,117 $ — $ — $ — State and municipal — — 6 — Residential mortgage-backed — — 328 (41) Asset-backed 304 (1) 277 (6) Other — — 8 — Total $ 1,421 $ (1) $ 619 $ (47) At December 31, 2023 U.S. government and federal agency $ 495 $ — $ 399 $ (1) State and municipal — — 9 — Residential mortgage-backed 1 — 346 (38) Asset-backed 171 — 244 (8) Other — — 8 — Total $ 667 $ — $ 1,006 $ (47)
Investments Classified by Contractual Maturity Date	Contractual Maturities of Investments in Available-for-Sale Debt Securities Amortized Estimated Weighted At March 31, 2024 ($ in millions) cost fair value Average yield (a) Due Within one year $ 1,923 $ 1,918 4.9 % After one year through five years $ 766 $ 766 5.2 % After five years through ten years $ 169 $ 157 1.8 % After ten years $ 193 $ 164 2.0 % _____________________ (a) Weighted average yield is calculated based on the amortized cost of each security. In calculating yield, no adjustment has been made with respect to any tax-exempt obligations.

Loan Receivables and Allowanc_2

Loan Receivables and Allowance for Credit Losses (Tables)	3 Months Ended
	Mar. 31, 2024
Receivables [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable	($ in millions) March 31, 2024 December 31, 2023 Credit cards $ 93,736 $ 97,043 Consumer installment loans 5,957 3,977 Commercial credit products 1,912 1,839 Other 128 129 Total loan receivables, before allowance for credit losses (a)(b)(c) $ 101,733 $ 102,988 _______________________ (a) Total loan receivables include $20.1 billion and $21.4 billion of restricted loans of consolidated securitization entities at March 31, 2024 and December 31, 2023, respectively. See Note 6. Variable Interest Entities for further information on these restricted loans. (b) At March 31, 2024 and December 31, 2023, loan receivables included deferred costs and purchase discounts, net of deferred income, of $(120) million and $213 million, respectively. (c) At March 31, 2024 and December 31, 2023, $23.2 billion and $22.4 billion, respectively, of loan receivables were pledged by the Bank as collateral to the Federal Reserve to secure Federal Reserve discount window advances.
Allowance for Credit Losses on Financing Receivables	Allowance for Credit Losses (a)(b) ($ in millions) Balance at Provision charged to operations (c) Gross charge-offs Recoveries Other (d) Balance at Credit cards $ 10,156 $ 1,508 $ (1,761) $ 291 $ — $ 10,194 Consumer installment loans 279 345 (90) 8 39 581 Commercial credit products 131 29 (35) 2 — 127 Other 5 (2) — — — 3 Total $ 10,571 $ 1,880 $ (1,886) $ 301 $ 39 $ 10,905 ($ in millions) Balance at Impact of ASU 2022-02 Adoption Post-Adoption Balance at January 1, 2023 Provision charged to operations Gross charge-offs Recoveries Balance at Credit cards $ 9,225 $ (294) $ 8,931 $ 1,159 $ (1,162) $ 224 $ 9,152 Consumer installment loans 208 1 209 85 (44) 5 255 Commercial credit products 87 (1) 85 48 (31) 2 104 Other 7 — 8 (2) — — 6 Total $ 9,527 $ (294) $ 9,233 $ 1,290 $ (1,237) $ 231 $ 9,517 _______________________ (a) The allowance for credit losses at March 31, 2024 and 2023 reflects our estimate of expected credit losses for the life of the loan receivables on our Condensed Consolidated Statements of Financial Position at March 31, 2024 and 2023 which include the consideration of current and expected macroeconomic conditions that existed at those dates. (b) Excluded from the table above are allowance for credit losses for loan receivables acquired and immediately written off within the period presented. (c) Provision for credit losses in the Condensed Consolidated Statements of Earnings for the three months ended March 31, 2024 includes $4 million associated with off-balance sheet credit exposures recorded in Accrued expenses and other liabilities in the Condensed Consolidated Statements of Financial Position. (d) Primarily represents allowance for credit losses for PCD assets.
Past Due Financing Receivables	Delinquent and Non-accrual Loans The following table provides information on our delinquent and non-accrual loans: At March 31, 2024 ($ in millions) 30-89 days delinquent 90 or more days delinquent Total past due 90 or more days delinquent and accruing Total non-accruing Credit cards $ 2,189 $ 2,377 $ 4,566 $ 2,377 $ — Consumer installment loans 121 33 154 — 33 Commercial credit products 51 49 100 49 — Total delinquent loans $ 2,361 $ 2,459 $ 4,820 $ 2,426 $ 33 Percentage of total loan receivables 2.3 % 2.4 % 4.7 % 2.4 % — % At December 31, 2023 ($ in millions) 30-89 days delinquent 90 or more days delinquent Total past due 90 or more days delinquent and accruing Total non-accruing Credit cards $ 2,375 $ 2,290 $ 4,665 $ 2,290 $ — Consumer installment loans 96 23 119 — 23 Commercial credit products 61 40 101 40 — Total delinquent loans $ 2,532 $ 2,353 $ 4,885 $ 2,330 $ 23 Percentage of total loan receivables 2.5 % 2.3 % 4.7 % 2.3 % — % Consumer Installment Loans by Origination Year By origination year At or for the three months ended 2024 2023 2022 2021 2020 Prior Total Amortized cost basis $ 809 $ 2,665 $ 1,470 $ 649 $ 287 $ 77 $ 5,957 30-89 days delinquent 4 53 38 16 7 3 121 90 or more days delinquent — 15 12 4 2 — 33 Current period gross charge-offs (a) — 47 25 12 5 1 90 By origination year At December 31, 2023 ($ in millions) 2023 2022 2021 2020 2019 Prior Total Amortized cost basis $ 2,097 $ 931 $ 541 $ 312 $ 69 $ 27 $ 3,977 30-89 days delinquent 44 25 15 9 2 1 96 90 or more days delinquent 11 6 4 2 — — 23 _______________________ (a) Gross charge-offs for the three months ended March 31, 2023 were not material.
Financing Receivable Credit Quality Indicators	The table below excludes 0.3%, 0.3% and 0.3% of our total loan receivables balance for our credit cards and commercial credit products at each of March 31, 2024, December 31, 2023 and March 31, 2023, respectively, which represents those customer accounts for which a VantageScore score, or equivalent, is not available. March 31, 2024 December 31, 2023 March 31, 2023 651 or 591 to 590 or 651 or 591 to 590 or 651 or 591 to 590 or higher 650 less higher 650 less higher 650 less Credit cards 71 % 20 % 9 % 72 % 19 % 9 % 73 % 19 % 8 % Commercial credit products 86 % 7 % 7 % 83 % 10 % 7 % 86 % 7 % 7 %
Schedule of Loan Modifications to Borrowers Experiencing Financial Difficulty	The following table provides information on our loan modifications made to borrowers experiencing financial difficulty during the periods presented, which do not include loans that are classified as loan receivables held for sale: Three months ended March 31 2024 2023 ($ in millions) Amount % of Loan Receivables Amount % of Loan Receivables Long-term modifications Credit cards $ 471 0.5 % $ 377 0.4 % Consumer installment loans — — — % Commercial credit products 2 0.1 % 1 0.1 % Short-term modifications Credit cards 247 0.3 % 139 0.2 % Consumer installment loans — — — % Commercial credit products — — — % Total $ 720 0.7 % $ 517 0.6 % Performance of Loans Modified to Borrowers Experiencing Financial Difficulty The following tables provide information on the performance of loans modified to borrowers experiencing financial difficulty which have been modified within the previous 12 months and remain in a modification program at March 31, 2024. For the comparative period, amounts represent loans that were modified subsequent to January 1, 2023 and remained in a modification program at March 31, 2023: Amortized cost basis At March 31, 2024 ($ in millions) Current 30-89 days delinquent 90 or more days delinquent Total past due (a) Long-term modifications Credit cards $ 928 $ 175 $ 151 $ 326 Consumer installment loans — — — — Commercial credit products 2 1 1 2 Short-term modifications Credit cards 71 41 50 91 Consumer installment loans — — — — Commercial credit products — — — — Total delinquent modified loans $ 1,001 $ 217 $ 202 $ 419 Percentage of total loan receivables 1.0 % 0.2 % 0.2 % 0.4 % Amortized cost basis At March 31, 2023 ($ in millions) Current 30-89 days delinquent 90 or more days delinquent Total past due (a) Long-term modifications Credit cards $ 209 $ 89 $ 65 $ 154 Consumer installment loans — — — — Commercial credit products — — 1 1 Short-term modifications Credit cards 28 18 44 62 Consumer installment loans — — — — Commercial credit products — — — — Total delinquent modified loans $ 237 $ 107 $ 110 $ 217 Percentage of total loan receivables 0.3 % 0.1 % 0.1 % 0.2 % ___________________ (a) Once a loan has been modified, it only returns to current status (re-aged) after three consecutive monthly program payments are received post the modification date.
Troubled Debt Restructurings on Financing Receivables, Subsequent Default	The following table presents the type, number and amount of loans to borrowers experiencing financial difficulty that enrolled in a long-term modification program within the previous 12 months from March 31, 2024, or between January 1, 2023 and March 31, 2023 for the comparative period, and experienced a payment default and charged-off during the period presented: Three months ended March 31 2024 2023 ($ in millions, accounts in thousands) Accounts defaulted Loans defaulted Accounts defaulted Loans defaulted Credit cards 47 $ 118 2 $ 7 Consumer installment loans — — — — Commercial credit products — 1 — — Total 47 $ 119 2 $ 7 Of the loans modified to borrowers experiencing financial difficulty that enrolled in a short-term modification program within the previous 12 months from March 31, 2024, or between January 1, 2023 and March 31, 2023 for the comparative period, 51% and 14% had fully completed all required payments and successfully exited the program during the three months ended March 31, 2024 and 2023, respectively.
Interest Income and Interest Expense Disclosure	The following table provides additional information about our interest and fees on loans, including merchant discounts, from our loan receivables, including held for sale: Three months ended March 31, ($ in millions) 2024 2023 Credit cards (a) $ 5,096 $ 4,497 Consumer installment loans 149 83 Commercial credit products 45 34 Other 3 2 Total (b) $ 5,293 $ 4,616 _______________________ (a) Interest income on credit cards that was reversed related to accrued interest receivables written off was $592 million and $415 million for the three months ended March 31, 2024 and 2023, respectively. (b) Deferred merchant discounts to be recognized in interest income at March 31, 2024 and December 31, 2023, were $1.8 billion and $1.9 billion, respectively, which are included in Accrued expenses and other liabilities in our Condensed Consolidated Statement of Financial Position.

Variable Interest Entities (Tab

Variable Interest Entities (Tables)	3 Months Ended
	Mar. 31, 2024
Variable Interest Entities [Abstract]
Schedule of Variable Interest Entities	The table below summarizes the assets and liabilities of our consolidated securitization VIEs described above: ($ in millions) March 31, 2024 December 31, 2023 Assets Loan receivables, net (a) $ 18,259 $ 19,537 Other assets (b) 49 47 Total $ 18,308 $ 19,584 Liabilities Borrowings $ 8,016 $ 7,267 Other liabilities 31 31 Total $ 8,047 $ 7,298 _______________________ (a) Includes $1.8 billion and $1.9 billion of related allowance for credit losses resulting in gross restricted loans of $20.1 billion and $21.4 billion at March 31, 2024 and December 31, 2023, respectively. (b) Includes $47 million and $45 million of segregated funds held by the VIEs at March 31, 2024 and December 31, 2023, respectively, which are classified as restricted cash and equivalents and included as a component of Other assets

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Goodwill ($ in millions) 2024 Balance at January 1 $ 1,018 Change in amounts allocated to disposition of business (a) 4 Goodwill recognized upon acquisition 51 Balance at March 31 $ 1,073 _____________ (a) The change in the three months ended March 31, 2024 was based upon the carrying amount of net assets of Pets Best and the final valuation of consideration received at closing.
Schedule of Finite-Lived Intangible Assets	March 31, 2024 December 31, 2023 ($ in millions) Gross carrying amount Accumulated amortization Net Gross carrying amount Accumulated amortization Net Capitalized software $ 2,066 $ (1,331) $ 735 $ 2,065 $ (1,302) $ 763 Other 191 (126) 65 204 (152) 52 Total $ 2,257 $ (1,457) $ 800 $ 2,269 $ (1,454) $ 815

Deposits (Tables)

Deposits (Tables)	3 Months Ended
	Mar. 31, 2024
Deposits [Abstract]
Schedule of Deposit Liabilities	March 31, 2024 December 31, 2023 ($ in millions) Amount Average rate (a) Amount Average rate (a) Interest-bearing deposits $ 83,160 4.6 % $ 80,789 3.9 % Non-interest-bearing deposits 394 — 364 — Total deposits $ 83,554 $ 81,153 ____________________ (a) Based on interest expense for the three months ended March 31, 2024 and the year ended December 31, 2023 and average deposits balances.
Schedule of Maturities of Deposit Liabilities	At March 31, 2024, our interest-bearing time deposits maturing for the remainder of 2024 and over the next four years and thereafter were as follows: ($ in millions) 2024 2025 2026 2027 2028 Thereafter Deposits $ 25,691 $ 17,744 $ 1,719 $ 2,726 $ 1,455 $ 282

Borrowings (Tables)

Borrowings (Tables)	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Schedule of Debt	March 31, 2024 December 31, 2023 ($ in millions) Maturity date Interest Rate Weighted average interest rate Outstanding Amount (a)(b) Outstanding Amount (a)(b) Borrowings of consolidated securitization entities: Fixed securitized borrowings 2025 - 2027 3.37% - 5.74% 4.69 % $ 4,166 $ 3,417 Floating securitized borrowings 2024 - 2026 6.07% - 6.28% 6.14 % 3,850 3,850 Total borrowings of consolidated securitization entities 5.39 % 8,016 7,267 Senior unsecured notes: Synchrony Financial senior unsecured notes: Fixed senior unsecured notes 2024 - 2031 2.87% - 5.15% 4.20 % 5,882 6,480 Synchrony Bank senior unsecured notes: Fixed senior unsecured notes 2025 - 2027 5.40% - 5.63% 5.49 % 1,494 1,494 Total senior unsecured notes 4.46 % 7,376 7,974 Subordinated unsecured notes: Synchrony Financial subordinated unsecured notes: Fixed subordinated unsecured notes 2033 7.25% 7.25 % 741 741 Total senior and subordinated unsecured notes 4.72 % 8,117 8,715 Total borrowings $ 16,133 $ 15,982 ___________________ (a) Includes unamortized debt premiums, discounts and issuance costs. (b) The Company may redeem certain borrowings prior to their original contractual maturity dates in accordance with the optional redemption provision specified in the respective instruments.
Schedule of Maturities of Long-term Debt	The following table summarizes the maturities of the principal amount of our borrowings of consolidated securitization entities and senior and subordinated unsecured notes for the remainder of 2024 and over the next four years and thereafter: ($ in millions) 2024 2025 2026 2027 2028 Thereafter Borrowings $ 2,875 $ 6,050 $ 2,750 $ 2,350 $ — $ 2,150

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value, Assets Measured on Recurring Basis	The following tables present our assets and liabilities measured at fair value on a recurring basis. Recurring Fair Value Measurements At March 31, 2024 ($ in millions) Level 1 Level 2 Level 3 Total (a) Assets Debt securities U.S. government and federal agency $ — $ 1,463 $ — $ 1,463 State and municipal — — 9 9 Residential mortgage-backed — 335 — 335 Asset-backed — 1,191 — 1,191 Other — — 8 8 Other (b) 14 — 9 23 Total $ 14 $ 2,989 $ 26 $ 3,029 Liabilities Other (c) — — 4 4 Total $ — $ — $ 4 $ 4 At December 31, 2023 ($ in millions) Assets Debt securities U.S. government and federal agency $ — $ 2,264 $ — $ 2,264 State and municipal — — 10 10 Residential mortgage-backed — 354 — 354 Asset-backed — 1,162 — 1,162 Other — — 8 8 Other (b) 14 — 10 24 Total $ 14 $ 3,780 $ 28 $ 3,822 Liabilities Other (c) — — $ 4 $ 4 Total $ — $ — $ 4 $ 4 _______________________ (a) For the three months ended March 31, 2024 and 2023, there were no fair value measurements transferred between levels. (b) Other is primarily comprised of equity investments measured at fair value, which are included in Other assets in our Condensed Consolidated Statement of Financial Position, as well as certain financial assets for which we have elected the fair value option which are included in Loan receivables in our Condensed Consolidated Statement of Financial Position. (c) Other is primarily comprised of certain financial liabilities for which we have elected the fair value option, which are included in Accrued expenses and other liabilities in our Condensed Consolidated Statement of Financial Position.
Fair Value, by Balance Sheet Grouping	Financial Assets and Financial Liabilities Carried at Other Than Fair Value Carrying Corresponding fair value amount At March 31, 2024 ($ in millions) value Total Level 1 Level 2 Level 3 Financial Assets Financial assets for which carrying values equal or approximate fair value: Cash and equivalents (a) $ 20,021 $ 20,021 $ 20,021 $ — $ — Other assets (a)(b) $ 50 $ 50 $ 50 $ — $ — Financial assets carried at other than fair value: Loan receivables, net (c) $ 90,819 $ 103,231 $ — $ — $ 103,231 Financial Liabilities Financial liabilities carried at other than fair value: Deposits $ 83,554 $ 83,516 $ — $ 83,516 $ — Borrowings of consolidated securitization entities $ 8,016 $ 8,001 $ — $ 4,150 $ 3,851 Senior and subordinated unsecured notes $ 8,117 $ 7,826 $ — $ 7,826 $ — Carrying Corresponding fair value amount At December 31, 2023 ($ in millions) value Total Level 1 Level 2 Level 3 Financial Assets Financial assets for which carrying values equal or approximate fair value: Cash and equivalents (a) $ 14,259 $ 14,259 $ 14,259 $ — $ — Other assets (a)(b) $ 50 $ 50 $ 50 $ — $ — Assets held for sale (d) $ 112 $ 112 $ 112 $ — $ — Financial assets carried at other than fair value: Loan receivables, net (c) $ 92,407 $ 104,761 $ — $ — $ 104,761 Financial Liabilities Financial liabilities carried at other than fair value: Deposits $ 81,153 $ 80,935 $ — $ 80,935 $ — Borrowings of consolidated securitization entities $ 7,267 $ 7,250 $ — $ 3,411 $ 3,839 Senior and subordinated unsecured notes $ 8,715 $ 8,423 $ — $ 8,423 $ — _______________________ (a) For cash and equivalents and restricted cash and equivalents, carrying value approximates fair value due to the liquid nature and short maturity of these instruments. (b) This balance relates to restricted cash and equivalents, which is included in Other assets. (c) Excludes financial assets for which we have elected the fair value option. Under certain retail partner program agreements, the expected sales proceeds in the event of a sale of their credit card portfolio may be limited to the amounts owed by our customers, which may be less than the fair value indicated above. (d) Includes $19 million of cash and equivalents and $93 million of restricted cash and equivalents.
Equity Securities without Readily Determinable Fair Value	Three months ended March 31, At or for the periods ended March 31 ($ in millions) 2024 2023 Carrying value (a) $ 272 $ 250 Upward adjustments (b) — — Downward adjustments (b) — — _______________________ (a) Carrying value reflects cumulative purchases and sales in addition to upward and downward carrying value changes, and at December 31, 2023 was $270 million.

Regulatory and Capital Adequa_2

Regulatory and Capital Adequacy (Tables)	3 Months Ended
	Mar. 31, 2024
Banking Regulation, Risk-Based Information [Abstract]
Schedule of Compliance with Regulatory Capital Requirements under Banking Regulations	The actual capital amounts, ratios and the applicable required minimums of the Company and the Bank are as follows: Synchrony Financial At March 31, 2024 ($ in millions) Actual Minimum for capital Amount Ratio (a) Amount Ratio (b) Total risk-based capital $ 16,347 15.8 % $ 8,259 8.0 % Tier 1 risk-based capital $ 14,207 13.8 % $ 6,195 6.0 % Tier 1 leverage $ 14,207 12.0 % $ 4,719 4.0 % Common equity Tier 1 Capital $ 12,985 12.6 % $ 4,646 4.5 % At December 31, 2023 ($ in millions) Actual Minimum for capital Amount Ratio (a) Amount Ratio (b) Total risk-based capital $ 15,464 14.9 % $ 8,277 8.0 % Tier 1 risk-based capital $ 13,334 12.9 % $ 6,208 6.0 % Tier 1 leverage $ 13,334 11.7 % $ 4,563 4.0 % Common equity Tier 1 Capital $ 12,600 12.2 % $ 4,656 4.5 % Synchrony Bank At March 31, 2024 ($ in millions) Actual Minimum for capital Minimum to be well-capitalized under prompt corrective action provisions Amount Ratio (a) Amount Ratio (b) Amount Ratio Total risk-based capital $ 14,769 15.1 % $ 7,840 8.0 % $ 9,800 10.0 % Tier 1 risk-based capital $ 12,690 12.9 % $ 5,880 6.0 % $ 7,840 8.0 % Tier 1 leverage $ 12,690 11.4 % $ 4,454 4.0 % $ 5,567 5.0 % Common equity Tier I capital $ 12,690 12.9 % $ 4,410 4.5 % $ 6,370 6.5 % At December 31, 2023 ($ in millions) Actual Minimum for capital Minimum to be well-capitalized under prompt corrective action provisions Amount Ratio (a) Amount Ratio (b) Amount Ratio Total risk-based capital $ 14,943 15.3 % $ 7,822 8.0 % $ 9,778 10.0 % Tier 1 risk-based capital $ 12,880 13.2 % $ 5,867 6.0 % $ 7,822 8.0 % Tier 1 leverage $ 12,880 12.0 % $ 4,302 4.0 % $ 5,377 5.0 % Common equity Tier I capital $ 12,880 13.2 % $ 4,400 4.5 % $ 6,356 6.5 % _______________________ (a) Capital ratios are calculated based on the Basel III Standardized Approach rules. Capital amounts and ratios at March 31, 2024 and at December 31, 2023 in the above tables reflect the applicable CECL regulatory capital transition adjustment. (b) At March 31, 2024 and at December 31, 2023, Synchrony Financial and the Bank also must maintain a capital conservation buffer of common equity Tier 1 capital in excess of minimum risk-based capital ratios by at least 2.5 percentage points to avoid limits on capital distributions and certain discretionary bonus payments to executive officers and similar employees.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table presents the calculation of basic and diluted earnings per common share: Three months ended March 31, (in millions, except per share data) 2024 2023 Net earnings $ 1,293 $ 601 Preferred stock dividends (11) (11) Net earnings available to common stockholders $ 1,282 $ 590 Weighted average common shares outstanding, basic 404.7 434.4 Effect of dilutive securities 3.5 2.8 Weighted average common shares outstanding, dilutive 408.2 437.2 Earnings per basic common share $ 3.17 $ 1.36 Earnings per diluted common share $ 3.14 $ 1.35

Equity and Other Stock Relate_2

Equity and Other Stock Related Information (Tables)	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
Schedule of Preferred Stock	The following table summarizes the Company's preferred stock issued and outstanding at March 31, 2024 and December 31, 2023. Series Issuance Date Redeemable by Issuer Beginning Per Annum Dividend Rate Liquidation Preference per Share Total Shares Outstanding March 31, 2024 December 31, 2023 ($ in millions, except per share data) Series A (a) November 14, 2019 November 15, 2024 5.625% $1,000 750,000 $ 734 $ 734 Series B (a) February 23, 2024 May 15, 2029 8.25% (b) $1,000 500,000 $ 488 $ — $ 1,222 $ 734 _______________________ (a) Issued as depositary shares, each representing a 1/40th interest in a share of the corresponding series of non-cumulative perpetual preferred stock. Dividends are payable quarterly on February 15, May 15, August 15 and November 15 of each calendar year at a fixed rate, in each case when, as and if declared by the Board of Directors. (b) Through May 14, 2029; resets May 15, 2029 and each date falling on the fifth anniversary at 5-Year Treasury Rate plus 4.044%.

Incomes Taxes (Tables)

Incomes Taxes (Tables)	3 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Unrecognized Tax Benefits	($ in millions) March 31, 2024 December 31, 2023 Unrecognized tax benefits, excluding related interest expense and penalties (a) $ 242 $ 230 Portion that, if recognized, would reduce tax expense and effective tax rate (b) $ 191 $ 182 ____________________ (a) Interest and penalties related to unrecognized tax benefits were not material for all periods presented. (b) Comprised of federal unrecognized tax benefits and state and local unrecognized tax benefits net of the effects of associated U.S. federal income taxes. Excludes amounts attributable to any related valuation allowances resulting from associated increases in deferred tax assets.

Acquisitions and Dispositions -

Acquisitions and Dispositions - Ally Lending Narrative (Details) - USD ($) $ in Millions	Mar. 01, 2024	Mar. 31, 2024	Mar. 05, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Business Combination, Separately Recognized Transactions [Line Items]
Allowance for credit loss		$ 10,905		$ 10,571	$ 9,517	$ 9,527
Ally Lending
Business Combination, Separately Recognized Transactions [Line Items]
Cash consideration	$ 1,969
Unpaid principal balance of loan receivables acquired			$ 2,200
Loan receivables provisional loan discount upon acquisition	271
Allowance for credit loss			$ 189
Purchased credit deteriorated loans acquired	64
Purchased credit deteriorated loans allowance	$ 39

Acquisitions and Dispositions_2

Acquisitions and Dispositions - Schedule of Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Millions	Mar. 01, 2024	Mar. 31, 2024	Mar. 05, 2024	Dec. 31, 2023
Liabilities assumed
Goodwill		$ 1,073		$ 1,018
Ally Lending
Assets acquired
Cash			$ 34
Loan receivables			1,875
Intangible assets, net			23
Other assets			2
Total			1,934
Liabilities assumed
Other liabilities			(16)
Total net identifiable assets acquired			1,918
Less: Total cash consideration paid	$ 1,969
Goodwill			$ 51

Acquisitions and Dispositions_3

Acquisitions and Dispositions - Pets Best Narrative (Details) $ in Millions	1 Months Ended	3 Months Ended
	Mar. 31, 2024 USD ($) executive	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Mar. 05, 2024 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain on sale of business		$ 1,069	$ 0
Independence Pet Holdings, Inc.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Equity method investments	$ 605	$ 605
Equity method investments, fair value				$ 605
Pets Best
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain on sale of business	1,100
Gain on sale of business, net of tax	$ 802
Pets Best | Independence Pet Holdings, Inc. | Synchrony Financial
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of executives appointed to Board of Directors | executive	2
Pets Best | Independence Pet Holdings, Inc.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Equity interests consideration received (less than)	10%

Debt Securities - Schedule of A

Debt Securities - Schedule of Available for Sale Securities (Details) - USD ($) $ in Millions		Mar. 31, 2024	Dec. 31, 2023
Debt
Amortized cost		$ 3,051	$ 3,841
Gross unrealized gains		2	5
Gross unrealized losses		(48)	(47)
Estimated fair value		3,005	3,799
U.S. government and federal agency
Debt
Amortized cost		1,463	2,264
Gross unrealized gains		0	1
Gross unrealized losses		0	(1)
Estimated fair value		1,463	2,264
State and municipal
Debt
Amortized cost		9	10
Gross unrealized gains		0	0
Gross unrealized losses		0	0
Estimated fair value		9	10
Residential mortgage-backed
Debt Securities, Available-for-sale [Line Items]
Residential Mortgage Backed Securities pledged as collateral to the Federal Reserve		344	360
Debt
Amortized cost	[1]	375	392
Gross unrealized gains	[1]	0	0
Gross unrealized losses	[1]	(41)	(38)
Estimated fair value	[1]	334	354
Asset-backed
Debt
Amortized cost	[2]	1,196	1,167
Gross unrealized gains	[2]	2	4
Gross unrealized losses	[2]	(7)	(8)
Estimated fair value	[2]	1,191	1,163
Other Debt Obligations
Debt
Amortized cost		8	8
Gross unrealized gains			0
Gross unrealized losses		0	0
Estimated fair value		$ 8	$ 8
[1] All of our residential mortgage-backed securities have been issued by government-sponsored entities and are collateralized by U.S. mortgages. Our asset-backed securities are collateralized by credit card and auto loans. (c) At March 31, 2024 and December 31, 2023, the estimated fair value of debt securities pledged by the Bank as collateral to the Federal Reserve to secure Federal Reserve discount window advances was $344 million and $360 million, respectively.

Debt Securities - Continuous Un

Debt Securities - Continuous Unrealized Losses (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Estimated fair value
Less than 12 months	$ 1,421	$ 667
12 months or more	619	1,006
Gross unrealized losses
Less than 12 months	(1)	0
12 months or more	(47)	(47)
U.S. government and federal agency
Estimated fair value
Less than 12 months	1,117	495
12 months or more	0	399
Gross unrealized losses
Less than 12 months	0	0
12 months or more	0	(1)
State and municipal
Estimated fair value
Less than 12 months	0	0
12 months or more	6	9
Gross unrealized losses
Less than 12 months	0	0
12 months or more	0	0
Residential mortgage-backed
Estimated fair value
Less than 12 months	0	1
12 months or more	328	346
Gross unrealized losses
Less than 12 months	0	0
12 months or more	(41)	(38)
Asset-backed
Estimated fair value
Less than 12 months	304	171
12 months or more	277	244
Gross unrealized losses
Less than 12 months	(1)	0
12 months or more	(6)	(8)
Other Debt Obligations
Estimated fair value
Less than 12 months	0	0
12 months or more	8	8
Gross unrealized losses
Less than 12 months	0	0
12 months or more	$ 0	$ 0

Debt Securities - Contractual M

Debt Securities - Contractual Maturities (Details) $ in Millions	Mar. 31, 2024 USD ($)
Amortized Cost
Within one year	$ 1,923
After one year through five years	766
After five years through ten years	169
After ten years	193
Estimated Fair Value
Within one year	1,918
After one year through five years	766
After five years through ten years	157
After ten years	$ 164
Weighted Average Yield
Within one year	4.90%	[1]
After one year through five years	5.20%	[1]
After five years through ten years	1.80%	[1]
After ten years	2%	[1]
[1] Weighted average yield is calculated based on the amortized cost of each security. In calculating yield, no adjustment has been made with respect to any tax-exempt obligations.

Loan Receivables and Allowanc_3

Loan Receivables and Allowance for Credit Losses - Loan Receivables (Details) - USD ($) $ in Millions		Mar. 31, 2024	Dec. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables	[1],[2]	$ 101,733	$ 102,988
Deferred costs and purchase discounts, net of deferred (income)		(120)	213
Federal Reserve Discount Window
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		23,200	22,400
Credit cards
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		93,736	97,043
Consumer installment loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		5,957	3,977
Commercial credit products
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		1,912	1,839
Other
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		128	129
Variable Interest Entity, Primary Beneficiary
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		$ 20,091	$ 21,434
[1] At March 31, 2024 and December 31, 2023, loan receivables included deferred costs and purchase discounts, net of deferred income, of $(120) million and $213 million, respectively. (c) At March 31, 2024 and December 31, 2023, $23.2 billion and $22.4 billion, respectively, of loan receivables were pledged by the Bank as collateral to the Federal Reserve to secure Federal Reserve discount window advances. Total loan receivables include $20.1 billion and $21.4 billion of restricted loans of consolidated securitization entities at March 31, 2024 and December 31, 2023, respectively. See Note 6. Variable Interest Entities for further information on these restricted loans.

Loan Receivables and Allowanc_4

Loan Receivables and Allowance for Credit Losses - Allowance for Credit Losses (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	$ 10,571	$ 9,527
Provision for credit losses	1,880
Provision for credit losses	1,884	1,290
Gross charge-offs	1,886	1,237
Recoveries	301	231
Other	39
Ending Balance	10,905	9,517
Financing Receivable, Credit Loss, Expense (Reversal), Accrued Forward Loan Portfolio Purchase	4
Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance		(294)
Cumulative Effect, Period of Adoption, Adjusted Balance
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	10,571	9,233
Credit cards
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance		9,225
Provision for credit losses	1,508
Provision for credit losses		1,159
Gross charge-offs	1,761	1,162
Recoveries	291	224
Other	0
Ending Balance	10,194	9,152
Credit cards | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance		(294)
Credit cards | Cumulative Effect, Period of Adoption, Adjusted Balance
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	10,156	8,931
Consumer installment loans
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance		208
Provision for credit losses	345
Provision for credit losses		85
Gross charge-offs	90	44
Recoveries	8	5
Other	39
Ending Balance	581	255
Consumer installment loans | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance		1
Consumer installment loans | Cumulative Effect, Period of Adoption, Adjusted Balance
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	279	209
Commercial credit products
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance		87
Provision for credit losses	29
Provision for credit losses		48
Gross charge-offs	35	31
Recoveries	2	2
Other	0
Ending Balance	127	104
Commercial credit products | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance		(1)
Commercial credit products | Cumulative Effect, Period of Adoption, Adjusted Balance
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	131	85
Other
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance		7
Provision for credit losses	(2)
Provision for credit losses		(2)
Gross charge-offs	0	0
Recoveries	0	0
Other	0
Ending Balance	3	6
Other | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance		0
Other | Cumulative Effect, Period of Adoption, Adjusted Balance
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	$ 5	$ 8

Loan Receivables and Allowanc_5

Loan Receivables and Allowance for Credit Losses - Delinquent and Non Accrual Status (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables	[1],[2]	$ 101,733		$ 102,988
90 or more days delinquent and accruing		2,426		2,330
Total non-accruing		$ 33		$ 23
Financing Receivable, Nonaccrual, Percent Past Due		0%		0%
Gross charge-offs		$ 1,886	$ 1,237
Credit cards
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		93,736		$ 97,043
90 or more days delinquent and accruing		2,377		2,290
Total non-accruing		0		0
Gross charge-offs		1,761	1,162
Consumer installment loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		5,957		3,977
90 or more days delinquent and accruing		0		0
Total non-accruing		33		23
Financing Receivable, Year One, Originated, Current Fiscal Year		809		2,097
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year		2,665		931
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year		1,470		541
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year		649		312
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year		287		69
Financing Receivable, Originated, More than Five Years before Current Fiscal Year		77		27
Financing Receivable Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff		47
Financing Receivable Year Three Originated Two Years Before Current FiscalYear Writeoff		25
Financing Receivable Year Four Originated Three Years Before Current Fiscal Year Writeoff		12
Financing Receivable Year Five Originated Four Years Before Current Fiscal Year Writeoff		5
Financing Receivable Originated More Than Five Years Before Current Fiscal Year Writeoff		1
Gross charge-offs		90	44
Commercial credit products
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		1,912		1,839
90 or more days delinquent and accruing		49		40
Total non-accruing		0		0
Gross charge-offs		35	31
Other
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		128		129
Gross charge-offs		0	$ 0
Financial Asset, Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		$ 4,820		$ 4,885
Financing Receivable, Percent Past Due		4.70%		4.70%
Financial Asset, Past Due | Credit cards
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		$ 4,566		$ 4,665
Financial Asset, Past Due | Consumer installment loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		154		119
Financial Asset, Past Due | Commercial credit products
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		100		101
Financing Receivables, 30 to 89 Days Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		$ 2,361		$ 2,532
Financing Receivable, Percent Past Due		2.30%		2.50%
Financing Receivables, 30 to 89 Days Past Due | Credit cards
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		$ 2,189		$ 2,375
Financing Receivables, 30 to 89 Days Past Due | Consumer installment loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		121		96
Financing Receivable, Year One, Originated, Current Fiscal Year		4		44
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year		53		25
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year		38		15
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year		16		9
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year		7		2
Financing Receivable, Originated, More than Five Years before Current Fiscal Year		3		1
Financing Receivables, 30 to 89 Days Past Due | Commercial credit products
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		51		61
Financial Asset, Equal to or Greater than 90 Days Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		$ 2,459		$ 2,353
Financing Receivable, Percent Past Due		2.40%		2.30%
Financial Asset, Equal to or Greater than 90 Days Past Due | Credit cards
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		$ 2,377		$ 2,290
Financial Asset, Equal to or Greater than 90 Days Past Due | Consumer installment loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		33		23
Financing Receivable, Year One, Originated, Current Fiscal Year		0		11
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year		15		6
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year		12		4
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year		4		2
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year		2		0
Financing Receivable, Originated, More than Five Years before Current Fiscal Year		0		0
Financial Asset, Equal to or Greater than 90 Days Past Due | Commercial credit products
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loan receivables		$ 49		$ 40
Financial Asset, Equal to or Greater than 90 Days Past Due And Accruing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Percent Past Due		2.40%		2.30%
[1] At March 31, 2024 and December 31, 2023, loan receivables included deferred costs and purchase discounts, net of deferred income, of $(120) million and $213 million, respectively. (c) At March 31, 2024 and December 31, 2023, $23.2 billion and $22.4 billion, respectively, of loan receivables were pledged by the Bank as collateral to the Federal Reserve to secure Federal Reserve discount window advances. Total loan receivables include $20.1 billion and $21.4 billion of restricted loans of consolidated securitization entities at March 31, 2024 and December 31, 2023, respectively. See Note 6. Variable Interest Entities for further information on these restricted loans.

Loan Receivables and Allowanc_6

Loan Receivables and Allowance for Credit Losses - Loans Entered into a Loan Modification Program (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total loans entered into a modification program	$ 720	$ 517
% of Loan Receivables	0.70%	0.60%
FinancingReceivableModifiedWeightedAverageInterestRateDecreaseFromModification	97%
Credit cards | Short-term Payment Deferral
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total loans entered into a modification program	$ 247	$ 139
% of Loan Receivables	0.30%	0.20%
Credit cards | Long-term Payment Deferral
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total loans entered into a modification program	$ 471	$ 377
% of Loan Receivables	0.50%	0.40%
Consumer installment loans | Short-term Payment Deferral
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total loans entered into a modification program	$ 0	$ 0
Consumer installment loans | Long-term Payment Deferral
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total loans entered into a modification program	0	0
Commercial credit products | Short-term Payment Deferral
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total loans entered into a modification program	0	0
Commercial credit products | Long-term Payment Deferral
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total loans entered into a modification program	$ 2	$ 1
% of Loan Receivables	0.10%	0.10%

Loan Receivables and Allowanc_7

Loan Receivables and Allowance for Credit Losses - Performance of Loans Modified to Borrowers Experiencing Financial Difficulty (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Financing Receivable, Troubled Debt Restructuring [Line Items]
% of Loan Receivables	0.70%	0.60%
Financial Asset, Not Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	$ 1,001	$ 237
% of Loan Receivables	1%	0.30%
Financial Asset, Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	$ 419	$ 217
% of Loan Receivables	0.40%	0.20%
Financing Receivables, 30 to 89 Days Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	$ 217	$ 107
% of Loan Receivables	0.20%	0.10%
Financial Asset, Equal to or Greater than 90 Days Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	$ 202	$ 110
% of Loan Receivables	0.20%	0.10%
Credit cards | Long-term Payment Deferral
Financing Receivable, Troubled Debt Restructuring [Line Items]
% of Loan Receivables	0.50%	0.40%
Credit cards | Long-term Payment Deferral | Financial Asset, Not Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	$ 928	$ 209
Credit cards | Long-term Payment Deferral | Financial Asset, Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	326	154
Credit cards | Long-term Payment Deferral | Financing Receivables, 30 to 89 Days Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	175	89
Credit cards | Long-term Payment Deferral | Financial Asset, Equal to or Greater than 90 Days Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	$ 151	$ 65
Credit cards | Short-term Payment Deferral
Financing Receivable, Troubled Debt Restructuring [Line Items]
% of Loan Receivables	0.30%	0.20%
Credit cards | Short-term Payment Deferral | Financial Asset, Not Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	$ 71	$ 28
Credit cards | Short-term Payment Deferral | Financial Asset, Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	91	62
Credit cards | Short-term Payment Deferral | Financing Receivables, 30 to 89 Days Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	41	18
Credit cards | Short-term Payment Deferral | Financial Asset, Equal to or Greater than 90 Days Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	50	44
Consumer installment loans | Long-term Payment Deferral | Financial Asset, Not Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	0	0
Consumer installment loans | Long-term Payment Deferral | Financial Asset, Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	0	0
Consumer installment loans | Long-term Payment Deferral | Financing Receivables, 30 to 89 Days Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	0	0
Consumer installment loans | Long-term Payment Deferral | Financial Asset, Equal to or Greater than 90 Days Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	0	0
Consumer installment loans | Short-term Payment Deferral | Financial Asset, Not Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	0	0
Consumer installment loans | Short-term Payment Deferral | Financial Asset, Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	0	0
Consumer installment loans | Short-term Payment Deferral | Financing Receivables, 30 to 89 Days Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	0	0
Consumer installment loans | Short-term Payment Deferral | Financial Asset, Equal to or Greater than 90 Days Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	$ 0	$ 0
Commercial credit products | Long-term Payment Deferral
Financing Receivable, Troubled Debt Restructuring [Line Items]
% of Loan Receivables	0.10%	0.10%
Commercial credit products | Long-term Payment Deferral | Financial Asset, Not Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	$ 2	$ 0
Commercial credit products | Long-term Payment Deferral | Financial Asset, Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	2	1
Commercial credit products | Long-term Payment Deferral | Financing Receivables, 30 to 89 Days Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	1	0
Commercial credit products | Long-term Payment Deferral | Financial Asset, Equal to or Greater than 90 Days Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	1	1
Commercial credit products | Short-term Payment Deferral | Financial Asset, Not Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	0	0
Commercial credit products | Short-term Payment Deferral | Financial Asset, Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	0	0
Commercial credit products | Short-term Payment Deferral | Financing Receivables, 30 to 89 Days Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	0	0
Commercial credit products | Short-term Payment Deferral | Financial Asset, Equal to or Greater than 90 Days Past Due
Financing Receivable, Troubled Debt Restructuring [Line Items]
Total delinquent modified loans	$ 0	$ 0

Loan Receivables and Allowanc_8

Loan Receivables and Allowance for Credit Losses - Payment Defaults (Details) contract in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2024 USD ($) contract	Mar. 31, 2023 USD ($) contract
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts defaulted | contract	47	2
Loans defaulted | $	$ 119	$ 7
Credit cards
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts defaulted | contract	47	2
Loans defaulted | $	$ 118	$ 7
Consumer installment loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts defaulted | contract	0	0
Loans defaulted | $	$ 0	$ 0
Commercial credit products
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts defaulted | contract	0	0
Loans defaulted | $	$ 1	$ 0

Loan Receivables and Allowanc_9

Loan Receivables and Allowance for Credit Losses - Credit Quality Indicators (Details)	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Credit Quality Indicators, Percentage of Loan Receivables with No Vantage Score	0.30%	0.30%	0.30%
Credit cards | Six Hundred and Fifty-One or Higher
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of class of loan receivable	71%	72%	73%
Credit cards | Five Hundred and Ninety-One to Six Hundred and Fifty
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of class of loan receivable	20%	19%	19%
Credit cards | Five Hundred and Ninety or Less
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of class of loan receivable	9%	9%	8%
Commercial credit products | Six Hundred and Fifty-One or Higher
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of class of loan receivable	86%	83%	86%
Commercial credit products | Five Hundred and Ninety-One to Six Hundred and Fifty
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of class of loan receivable	7%	10%	7%
Commercial credit products | Five Hundred and Ninety or Less
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of class of loan receivable	7%	7%	7%

Loan Receivables and Allowan_10

Loan Receivables and Allowance for Credit Losses - Interest Income by Product (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest and fees on loans	[1]	$ 5,293	$ 4,616
Contract with Customer, Liability		1,800		$ 1,900
Credit cards
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest and fees on loans	[2]	5,096	4,497
Financing Receivable, Accrued Interest, Writeoff		592	415
Consumer installment loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest and fees on loans		149	83
Commercial credit products
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest and fees on loans		45	34
Other
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest and fees on loans		$ 3	$ 2
[1] Deferred merchant discounts to be recognized in interest income at March 31, 2024 and December 31, 2023, were $1.8 billion and $1.9 billion, respectively, which are included in Accrued expenses and other liabilities in our Condensed Consolidated Statement of Financial Position.

Loan Receivables and Allowan_11

Loan Receivables and Allowance for Credit Losses - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Allowance for Credit Loss, Reasonable and Supportable Forecast Period	12 months
Financing Receivable, Allowance for Credit Loss, Reversion Period	6 months
Financing Receivable, Troubled Debt Restructuring, Success Rate	51%	14%
FinancingReceivableModifiedWeightedAverageInterestRateDecreaseFromModification	97%
Financing Receivable Modified Percent of Unpaid Balance Forgiven Short-term	$ 15	$ 11
Financing Receivable, Allowance for Credit Loss, Writeoff	(1,886)	(1,237)
Credit cards
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unused Commitments to Extend Credit	428,000		$ 427,000
Financing Receivable, Allowance for Credit Loss, Writeoff	(1,761)	(1,162)
Consumer installment loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Allowance for Credit Loss, Writeoff	$ (90)	$ (44)

Variable Interest Entities - Su

Variable Interest Entities - Summary of Assets and Liabilities (Details) - USD ($) $ in Millions		Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Variable Interest Entity [Line Items]
Loan receivables, net		$ 90,828	$ 92,417
Other assets		5,446	4,915
Total assets		121,173	117,479
Total liabilities		105,891	103,576
Financing Receivable, Allowance for Credit Loss		(10,905)	(10,571)	$ (9,517)	$ (9,527)
Total loan receivables	[1],[2]	$ 101,733	$ 102,988
Restricted Cash Equivalents, Statement of Financial Position [Extensible Enumeration]		Other assets	Other assets
Variable Interest Entity, Primary Beneficiary
Variable Interest Entity [Line Items]
Loan receivables, net	[3]	$ 18,259	$ 19,537
Other assets	[4]	49	47
Total assets		18,308	19,584
Borrowings	[5]	8,016	7,267
Other liabilities		31	31
Total liabilities		8,047	7,298
Financing Receivable, Allowance for Credit Loss		(1,800)	(1,900)
Total loan receivables		20,091	21,434
Restricted Cash Equivalents		$ 47	$ 45
[1] At March 31, 2024 and December 31, 2023, loan receivables included deferred costs and purchase discounts, net of deferred income, of $(120) million and $213 million, respectively. (c) At March 31, 2024 and December 31, 2023, $23.2 billion and $22.4 billion, respectively, of loan receivables were pledged by the Bank as collateral to the Federal Reserve to secure Federal Reserve discount window advances. Total loan receivables include $20.1 billion and $21.4 billion of restricted loans of consolidated securitization entities at March 31, 2024 and December 31, 2023, respectively. See Note 6. Variable Interest Entities for further information on these restricted loans. Includes $1.8 billion and $1.9 billion of related allowance for credit losses resulting in gross restricted loans of $20.1 billion and $21.4 billion at March 31, 2024 and December 31, 2023, respectively. Other assets Includes unamortized debt premiums, discounts and issuance costs. (b) The Company may redeem certain borrowings prior to their original contractual maturity dates in accordance with the optional redemption provision specified in the respective instruments.

Variable Interest Entities - Na

Variable Interest Entities - Narrative (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Variable Interest Entity [Line Items]
Interest and fees on loans	[1]	$ 5,293	$ 4,616
Provision for credit losses		1,884	1,290
Affordable housing properties investments		713		$ 736
Amortization of affordable housing properties investments		23	20
Tax credits and other benefits of affordable housing properties investments		(28)	(24)
Other investments in non-consolidated VIEs		259		$ 252
Investments Funding Commitment
Variable Interest Entity [Line Items]
Other commitments		192
Variable Interest Entity, Primary Beneficiary
Variable Interest Entity [Line Items]
Interest and fees on loans		1,000	948
Provision for credit losses		165	120
Interest on borrowings of consolidated securitization entities		$ 105	$ 77
[1] Deferred merchant discounts to be recognized in interest income at March 31, 2024 and December 31, 2023, were $1.8 billion and $1.9 billion, respectively, which are included in Accrued expenses and other liabilities in our Condensed Consolidated Statement of Financial Position.

Intangible Assets - Schedule of

Intangible Assets - Schedule of Goodwill (Details) $ in Millions	3 Months Ended
	Mar. 31, 2024 USD ($)
Goodwill [Roll Forward]
Balance at January 1	$ 1,018
Change in amounts allocated to disposition of business	4
Goodwill recognized upon acquisition	51
Balance at March 31	$ 1,073

Intangible Assets - Schedule _2

Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 2,257	$ 2,269
Accumulated amortization	(1,457)	(1,454)
Net	800	815
Capitalized software
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	2,066	2,065
Accumulated amortization	(1,331)	(1,302)
Net	735	763
Other Intangible Assets
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	191	204
Accumulated amortization	(126)	(152)
Net	$ 65	$ 52

Intangible Assets Narrative (De

Intangible Assets Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 05, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets acquired	$ 64
Other Assets	5,446			$ 4,915
Ally Lending
Finite-Lived Intangible Assets [Line Items]
Intangible assets, net			$ 23
Other Expense | Finite-Lived Intangible Assets, Excluding Retail Partner Contracts
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 80	$ 70

Deposits - Schedule of Deposit

Deposits - Schedule of Deposit Liabilities (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Deposits [Abstract]
Interest-bearing deposits, amount		$ 83,160		$ 80,789
Non-interest-bearing deposits, amount		394		364
Total deposits		$ 83,554		$ 81,153
Weighted Average Rate, Interest-Bearing Domestic Deposits, over Time	[1]	4.60%	3.90%
[1] Based on interest expense for the three months ended March 31, 2024 and the year ended December 31, 2023 and average deposits balances.

Deposits - Maturity Schedule (D

Deposits - Maturity Schedule (Details) $ in Millions	Mar. 31, 2024 USD ($)
Maturities of Time Deposits [Abstract]
2024	$ 25,691
2025	17,744
2026	1,719
2027	2,726
2028	1,455
Thereafter	$ 282

Deposits - Narrative (Details)

Deposits - Narrative (Details) - USD ($) $ in Billions	Mar. 31, 2024	Dec. 31, 2023
Schedule of Deposits [Line Items]
Time Deposits, at or Above FDIC Insurance Limit	$ 10.7	$ 10
Demand deposits with no defined maturity	29.3
Deposits, Savings Deposits	27.3
Program Arranger
Schedule of Deposits [Line Items]
Broker network deposit sweeps	$ 4.3

Borrowings - Borrowings Schedul

Borrowings - Borrowings Schedule (Details) - USD ($) $ in Millions		Mar. 31, 2024	Dec. 31, 2023
Amount
Total borrowings	[1]	$ 16,133	$ 15,982
Senior unsecured notes
Amount
Unsecured debt	[1]	$ 7,376	7,974
Average rate
Weighted average interest rate		4.46%
Senior and Subordinated Notes
Amount
Unsecured debt		$ 8,117	8,715
Average rate
Weighted average interest rate		4.72%
Fixed Senior Unsecured Notes | Senior unsecured notes
Amount
Unsecured debt	[1]	$ 5,882	6,480
Average rate
Weighted average interest rate		4.20%
Fixed Subordinated Unsecured Notes | Senior Subordinated Notes
Amount
Unsecured debt		$ 741	741
Average rate
Weighted average interest rate		7.25%
Variable Interest Entity, Primary Beneficiary
Average rate
Weighted average interest rate		5.39%
Borrowings of consolidated securitization entities	[1]	$ 8,016	7,267
Variable Interest Entity, Primary Beneficiary | Fixed Securitized Borrowings
Average rate
Weighted average interest rate		4.69%
Borrowings of consolidated securitization entities	[1]	$ 4,166	3,417
Variable Interest Entity, Primary Beneficiary | Floating Securitized Borrowings
Average rate
Weighted average interest rate		6.14%
Borrowings of consolidated securitization entities	[1]	$ 3,850	3,850
Subsidiaries [Member] | Fixed Senior Unsecured Notes | Senior unsecured notes
Amount
Unsecured debt	[1]	$ 1,494	$ 1,494
Average rate
Weighted average interest rate		5.49%
Minimum | Fixed Senior Unsecured Notes | Senior unsecured notes
Average rate
Debt Instrument, Interest Rate, Stated Percentage		2.87%
Minimum | Fixed Subordinated Unsecured Notes | Senior Subordinated Notes
Average rate
Debt Instrument, Interest Rate, Stated Percentage		7.25%
Minimum | Variable Interest Entity, Primary Beneficiary | Fixed Securitized Borrowings
Average rate
Debt Instrument, Interest Rate, Stated Percentage		3.37%
Minimum | Variable Interest Entity, Primary Beneficiary | Floating Securitized Borrowings
Average rate
Debt Instrument, Interest Rate, Stated Percentage		6.07%
Minimum | Subsidiaries [Member] | Fixed Senior Unsecured Notes | Senior unsecured notes
Average rate
Debt Instrument, Interest Rate, Stated Percentage		5.40%
Maximum | Fixed Senior Unsecured Notes | Senior unsecured notes
Average rate
Debt Instrument, Interest Rate, Stated Percentage		5.15%
Maximum | Fixed Subordinated Unsecured Notes | Senior Subordinated Notes
Average rate
Debt Instrument, Interest Rate, Stated Percentage		7.25%
Maximum | Variable Interest Entity, Primary Beneficiary | Fixed Securitized Borrowings
Average rate
Debt Instrument, Interest Rate, Stated Percentage		5.74%
Maximum | Variable Interest Entity, Primary Beneficiary | Floating Securitized Borrowings
Average rate
Debt Instrument, Interest Rate, Stated Percentage		6.28%
Maximum | Subsidiaries [Member] | Fixed Senior Unsecured Notes | Senior unsecured notes
Average rate
Debt Instrument, Interest Rate, Stated Percentage		5.63%
[1] Includes unamortized debt premiums, discounts and issuance costs. (b) The Company may redeem certain borrowings prior to their original contractual maturity dates in accordance with the optional redemption provision specified in the respective instruments.

Borrowings - Borrowings Maturit

Borrowings - Borrowings Maturity Schedule (Details) $ in Millions	Mar. 31, 2024 USD ($)
Maturities of Long-Term Debt [Abstract]
2024	$ 2,875
2025	6,050
2026	2,750
2027	2,350
2028	0
Thereafter	$ 2,150

Borrowings - Narrative (Details

Borrowings - Narrative (Details) - USD ($) $ in Billions	Mar. 31, 2024	Dec. 31, 2023
Federal Reserve Discount Window
Debt Instrument [Line Items]
Remaining undrawn capacity	$ 10.8	$ 10.4
Variable Interest Entity, Primary Beneficiary
Debt Instrument [Line Items]
Remaining undrawn capacity	2.5	2.5
Revolving Credit Facility | Unsecured Debt
Debt Instrument [Line Items]
Undrawn capacity	$ 0.5	$ 0.5
Maximum | Senior Notes | Fixed Senior Unsecured Notes
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	5.15%
Maximum | Senior Notes | Fixed Senior Unsecured Notes | Subsidiaries [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	5.63%

Fair Value Measurement - Recurr

Fair Value Measurement - Recurring Fair Value Measurements (Details) - USD ($) $ in Millions		Mar. 31, 2024		Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		$ 3,005		$ 3,799
Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	[1]	3,029		3,822
Business Combination, Contingent Consideration, Liability		4	[1]	4
Financial and Nonfinancial Liabilities, Fair Value Disclosure	[1]	4		4
Assets measured at fair value, Other		23	[1]	24
Fair Value, Measurements, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total		14		14
Business Combination, Contingent Consideration, Liability		0		0
Financial and Nonfinancial Liabilities, Fair Value Disclosure		0		0
Assets measured at fair value, Other		14		14
Fair Value, Measurements, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total		2,989		3,780
Business Combination, Contingent Consideration, Liability		0		0
Financial and Nonfinancial Liabilities, Fair Value Disclosure		0		0
Assets measured at fair value, Other		0		0
Fair Value, Measurements, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total		26		28
Business Combination, Contingent Consideration, Liability		4		4
Financial and Nonfinancial Liabilities, Fair Value Disclosure		4		4
Assets measured at fair value, Other		9		10
U.S. government and federal agency
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		1,463		2,264
U.S. government and federal agency | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)	[1]	1,463		2,264
U.S. government and federal agency | Fair Value, Measurements, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		0		0
U.S. government and federal agency | Fair Value, Measurements, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		1,463		2,264
U.S. government and federal agency | Fair Value, Measurements, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		0		0
State and municipal
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		9		10
State and municipal | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)	[1]	9		10
State and municipal | Fair Value, Measurements, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		0		0
State and municipal | Fair Value, Measurements, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		0		0
State and municipal | Fair Value, Measurements, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		9		10
Residential mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)	[2]	334		354
Residential mortgage-backed | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)	[1]	335		354
Residential mortgage-backed | Fair Value, Measurements, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		0		0
Residential mortgage-backed | Fair Value, Measurements, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		335		354
Residential mortgage-backed | Fair Value, Measurements, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		0		0
Asset-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)	[3]	1,191		1,163
Asset-backed | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)	[1]	1,191		1,162
Asset-backed | Fair Value, Measurements, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		0		0
Asset-backed | Fair Value, Measurements, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		1,191		1,162
Asset-backed | Fair Value, Measurements, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		0		0
Other Debt Obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		8		8
Other Debt Obligations | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		8		8
Other Debt Obligations | Fair Value, Measurements, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		0		0
Other Debt Obligations | Fair Value, Measurements, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		0		0
Other Debt Obligations | Fair Value, Measurements, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities (Note 4)		$ 8		$ 8
[1]For the three months ended March 31, 2024 and 2023, there were no fair value measurements transferred between levels.[2] All of our residential mortgage-backed securities have been issued by government-sponsored entities and are collateralized by U.S. mortgages. Our asset-backed securities are collateralized by credit card and auto loans. (c) At March 31, 2024 and December 31, 2023, the estimated fair value of debt securities pledged by the Bank as collateral to the Federal Reserve to secure Federal Reserve discount window advances was $344 million and $360 million, respectively.

Fair Value Measurement - Fair V

Fair Value Measurement - Fair Value Asset and Liabilities Carried at Other than Fair Value (Details) - USD ($) $ in Millions	Mar. 31, 2024		Dec. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and equivalents	$ 20,021	[1]	$ 14,259
Other assets	50	[1],[2]	50
Loan receivables, net	103,231	[3]	104,761
Deposits	83,516		80,935
Disposal Group, Including Discontinued Operations, Restricted Cash			93
Disposal Group, Including Discontinued Operation, Cash			19
Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and equivalents	20,021		14,259
Other assets	50		50
Loan receivables, net	90,819		92,407
Deposits	83,554		81,153
Assets Held for Sale, Fair Value Disclosure			112
Estimate of Fair Value Measurement
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets Held for Sale, Fair Value Disclosure			112
Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and equivalents	20,021		14,259
Other assets	50		50
Loan receivables, net	0	[3]	0
Deposits	0		0
Assets Held for Sale, Fair Value Disclosure			112
Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and equivalents	0		0
Other assets	0	[1],[2]	0
Loan receivables, net	0	[3]	0
Deposits	83,516		80,935
Assets Held for Sale, Fair Value Disclosure			0
Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and equivalents	0	[1]	0
Other assets	0	[1],[2]	0
Loan receivables, net	103,231		104,761
Deposits	0		0
Assets Held for Sale, Fair Value Disclosure			0
Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Instrument, Fair Value Disclosure	7,826		8,423
Senior Notes | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Instrument, Fair Value Disclosure	8,117		8,715
Senior Notes | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Instrument, Fair Value Disclosure	0		0
Senior Notes | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Instrument, Fair Value Disclosure	7,826		8,423
Senior Notes | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Instrument, Fair Value Disclosure	0		0
Variable Interest Entity, Primary Beneficiary
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Borrowings of consolidated securitization entities	8,001		7,250
Variable Interest Entity, Primary Beneficiary | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Borrowings of consolidated securitization entities	8,016		7,267
Variable Interest Entity, Primary Beneficiary | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Borrowings of consolidated securitization entities	0		0
Variable Interest Entity, Primary Beneficiary | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Borrowings of consolidated securitization entities	4,150		3,411
Variable Interest Entity, Primary Beneficiary | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Borrowings of consolidated securitization entities	$ 3,851		$ 3,839
[1] For cash and equivalents and restricted cash and equivalents, carrying value approximates fair value due to the liquid nature and short maturity of these instruments. This balance relates to restricted cash and equivalents, which is included in Other assets. (c) Excludes financial assets for which we have elected the fair value option. Under certain retail partner program agreements, the expected sales proceeds in the event of a sale of their credit card portfolio may be limited to the amounts owed by our customers, which may be less than the fair value indicated above.

Equity Securities without Readi

Equity Securities without Readily Determinable Fair Value (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2024		Mar. 31, 2023		Dec. 31, 2023
Fair Value Disclosures [Abstract]
Carry Value		$ 272	[1]	$ 250	[1]	$ 270
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount	[2]	0		0
Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount	[2]	0		$ 0
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount		205
Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount		$ (14)
[1]December 31, 2023 was $270 million.[2]Between January 1, 2018 and March 31, 2024, cumulative upward and downward carrying value adjustments were $205 million and $(14) million, respectively.

Regulatory and Capital Adequa_3

Regulatory and Capital Adequacy (Capital Amounts and Ratios) (Details) - Basel III $ in Millions		Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Capital conservation buffer		0.025	0.025
Total risk-based capital
Actual		$ 16,347	$ 15,464
Actual (percent)	[1]	0.158	0.149
Minimum for capital adequacy purposes		$ 8,259	$ 8,277
Minimum for capital adequacy purposes (percent)	[2]	0.080	0.080
Tier 1 risk-based capital
Banking Regulation, Tier One Risk-Based Capital, Actual		$ 14,207	$ 13,334
Actual (percent)	[1]	0.138	0.129
Minimum for capital adequacy purposes		$ 6,195	$ 6,208
Minimum for capital adequacy purposes (percent)	[2]	0.060	0.060
Tier 1 leverage
Banking Regulation, Tier One Leverage Capital, Actual		$ 14,207	$ 13,334
Actual (percent)	[1]	0.120	0.117
Minimum for capital adequacy purposes		$ 4,719	$ 4,563
Minimum for capital adequacy purposes (percent)	[2]	0.040	0.040
Common equity Tier I capital
Common equity, actual		$ 12,985	$ 12,600
Common equity, actual (percent)	[1]	0.126	0.122
Common equity, minimum for capital adequacy purposes		$ 4,646	$ 4,656
Common Equity Tier One Capital Required for Capital Adequacy to Risk Weighted Assets	[2]	0.045	0.045
Synchrony Bank
Total risk-based capital
Actual		$ 14,769	$ 14,943
Actual (percent)	[1]	0.151	0.153
Minimum for capital adequacy purposes		$ 7,840	$ 7,822
Minimum for capital adequacy purposes (percent)	[2]	0.080	0.080
Minimum to be well-capitalized under prompt corrective action provisions		$ 9,800	$ 9,778
Minimum to be well-capitalized under prompt corrective action provisions (percent)		0.100	0.100
Tier 1 risk-based capital
Banking Regulation, Tier One Risk-Based Capital, Actual		$ 12,690	$ 12,880
Actual (percent)	[1]	0.129	0.132
Minimum for capital adequacy purposes		$ 5,880	$ 5,867
Minimum for capital adequacy purposes (percent)	[2]	0.060	0.060
Minimum to be well-capitalized under prompt corrective action provisions		$ 7,840	$ 7,822
Minimum to be well-capitalized under prompt corrective action provisions (percent)		0.080	0.080
Tier 1 leverage
Banking Regulation, Tier One Leverage Capital, Actual		$ 12,690	$ 12,880
Actual (percent)	[1]	0.114	0.120
Minimum for capital adequacy purposes		$ 4,454	$ 4,302
Minimum for capital adequacy purposes (percent)	[2]	0.040	0.040
Minimum to be well-capitalized under prompt corrective action provisions		$ 5,567	$ 5,377
Minimum to be well-capitalized under prompt corrective action provisions (percent)		0.050	0.050
Common equity Tier I capital
Common equity, actual		$ 12,690	$ 12,880
Common equity, actual (percent)	[1]	0.129	0.132
Common equity, minimum for capital adequacy purposes		$ 4,410	$ 4,400
Common Equity Tier One Capital Required for Capital Adequacy to Risk Weighted Assets	[2]	0.045	0.045
Common equity, minimum to be well-capitalized under prompt corrective action provisions		$ 6,370	$ 6,356
Common Equity Tier One Capital Required to be Well Capitalized Risk Weighted Assets		0.065	0.065
[1] Capital ratios are calculated based on the Basel III Standardized Approach rules. Capital amounts and ratios at March 31, 2024 and at December 31, 2023 in the above tables reflect the applicable CECL regulatory capital transition adjustment. At March 31, 2024 and at December 31, 2023, Synchrony Financial and the Bank also must maintain a capital conservation buffer of common equity Tier 1 capital in excess of minimum risk-based capital ratios by at least 2.5 percentage points to avoid limits on capital distributions and certain discretionary bonus payments to executive officers and similar employees.

Earnings Per Share - Basic and

Earnings Per Share - Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Earnings Per Share [Abstract]
Net earnings	$ 1,293	$ 601
Preferred stock dividends	(11)	(11)
Net earnings available to common stockholders	$ 1,282	$ 590
Weighted average common shares outstanding, basic (in shares)	404.7	434.4
Effect of dilutive securities (in shares)	3.5	2.8
Weighted average common shares outstanding, dilutive (in shares)	408.2	437.2
Earnings per basic common share (in usd per share)	$ 3.17	$ 1.36
Earnings per diluted common share (in usd per share)	$ 3.14	$ 1.35

Earnings Per Share - Narrative

Earnings Per Share - Narrative (Details) - shares shares in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Earnings Per Share [Abstract]
Antidilutive securities excluded from computation of earnings per share, amount	2	5

Equity and Other Stock Relate_3

Equity and Other Stock Related Information - Schedule of Preferred Stock (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Class of Stock [Line Items]
Total shares outstanding (in shares)	1,250,000	750,000
Preferred stock issued	$ 1,222	$ 734
Series A Preferred Stock
Class of Stock [Line Items]
Per Annum Dividend Rate	5.625%
Liquidation Preference Per Share (in usd per share)	$ 1,000
Total shares outstanding (in shares)	750,000
Preferred stock issued	$ 734	734
Series B Preferred Stock
Class of Stock [Line Items]
Per Annum Dividend Rate	825%
Liquidation Preference Per Share (in usd per share)	$ 1,000
Total shares outstanding (in shares)	500,000
Preferred stock issued	$ 488	$ 0
Series B Preferred Stock | Five-Year Treasury Rate
Class of Stock [Line Items]
Preferred Stock, Dividend Payment Rate, Variable	4.044

Income Taxes - Unrecognized Tax

Income Taxes - Unrecognized Tax Benefits (Details) - USD ($) $ in Millions		Mar. 31, 2024	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Portion that, if recognized, would reduce tax expense and effective tax rate	[1]	$ 191	$ 182
Unrecognized tax benefits, excluding related interest expense and penalties	[2]	242	$ 230
Decrease in Unrecognized Tax Benefits is Reasonably Possible		39
Decrease in Unrecognized Tax Benefits That Would Impact Effective Tax Rate		$ 31
[1] Comprised of federal unrecognized tax benefits and state and local unrecognized tax benefits net of the effects of associated U.S. federal income taxes. Excludes amounts attributable to any related valuation allowances resulting from associated increases in deferred tax assets. Interest and penalties related to unrecognized tax benefits were not material for all periods presented.

Uncategorized Items - syf-20240

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2016-13 [Member]
Treasury Stock, Value, Acquired, Cost Method	us-gaap_TreasuryStockValueAcquiredCostMethod	$ 404,000,000